Trochanteric bursitis

M13_TROCHANTERICBURSITIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M70.6 Hospital discharge: ICD-9 — 7265A Cause of death: ICD-10 — M70.6 Cause of death: ICD-9 — 7265A 2 out of 7 registries used, show all original rules.	7665
4. Check minimum number of events None	7665
5. Include endpoints None	7665
6. Filter based on genotype QC (FinnGen only)	6958

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M70
Name in latin: Bursitis trochanterica

NAME	M13_TROCHANTERICBURSITIS
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M706
HD_ICD_9	7265A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M706
COD_ICD_9	7265A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Trochanteric bursitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30347	24940	5300
Only index persons	29148	24158	4990
Unadjusted period prevalence (%)
Whole population	0.61	0.71	0.15
Only index persons	0.77	0.89	0.19
Median age at first event (years)
Whole population	61.31	61.11	62.38
Only index persons	60.92	60.71	61.95

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6958	5833	1125
Unadjusted period prevalence (%)	1.82	2.07	0.52
Median age at first event (years)	62.05	61.31	65.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7159: Matched controls
71590

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M54.3

ICD-10 Finland

Sciatica

4.9

321.7

770

1726

A02BC02

ATC

pantoprazole; systemic

3.1

320.8

5718

40417

NF1AA

NOMESCO Finland

Hip X-ray examination

3.7

314.4

1120

3379

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

26.8

307.7

617

251

M01AB05

ATC

diclofenac; systemic, rectal

3.0

307.7

5417

36392

M03BX02

ATC

tizanidine; oral

3.2

307.7

5308

33950

M01AH05

ATC

etoricoxib; oral

4.4

307.7

5716

34101

N03AX12

ATC

[U] gabapentin; oral

6.0

307.7

2219

5014

N06AA09

ATC

amitriptyline; systemic

4.1

307.7

1106

3048

N02AX02

ATC

tramadol; systemic, rectal

4.3

307.7

4316

18833

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

5.2

307.7

1880

4592

L08

ICPC

Shoulder symptom/complaint

2.9

307.7

2210

9457

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

12.5

307.7

731

646

N06AX21

ATC

duloxetine; oral

5.4

307.7

1664

3790

N03AX16

ATC

[U] pregabalin

5.2

307.7

2944

8498

N02BF01

ATC

gabapentin; oral

5.0

307.7

1396

3280

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

6.5

307.7

1244

2233

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.2

307.7

1937

4749

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.6

307.7

1277

3217

M76.0

ICD-10 Finland

Gluteal tendinitis

16.1

307.7

568

381

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.2

307.7

3972

20208

M03BC01

ATC

orphenadrine (citrate); systemic

3.1

307.7

2176

8855

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

6.1

307.7

863

1572

R51.80

ICD-10 Finland

Headache

3.3

307.7

1531

5516

M54.5

ICD-10 Finland

Low back pain

4.4

307.7

4091

16755

M25.5

ICD-10 Finland

Pain in joint

4.4

307.7

3794

14705

M16.1

ICD-10 Finland

Other primary coxarthrosis

3.4

307.7

1412

4859

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

307.7

3406

17208

M54.4

ICD-10 Finland

Lumbago with sciatica

5.7

307.7

2639

6699

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

10.5

307.7

418

421

M79.7

ICD-10 Finland

Fibromyalgia

16.3

307.7

579

384

M70.7

ICD-10 Finland

Other bursitis of hip

10.0

307.7

588

633

N02AJ06

ATC

codeine and paracetamol; systemic

3.4

307.7

4027

19770

L03

ICPC

Low back symptom/complaint

3.4

307.7

3153

13520

G44.2

ICD-10 Finland

Tension-type headache

3.3

307.7

1481

5212

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

46.7

307.7

213

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

13.0

307.7

730

622

M75.1

ICD-10 Finland

Rotator cuff syndrome

5.7

307.7

2758

7102

M19.0

ICD-10 Finland

Primary arthrosis of other joints

4.4

307.7

1159

2992

M79.1

ICD-10 Finland

Myalgia

4.1

307.7

1567

4575

M01AH01

ATC

celecoxib; oral

3.2

307.7

1905

7279

TNX00, ,

SPAT

14.8

307.7

331

233

M01AC06

ATC

meloxicam; systemic, rectal

2.7

307.7

3398

17905

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

7.0

307.7

1682

3005

M70.6

ICD-10 Finland

Trochanteric bursitis

1724.7

307.7

7106

5164

L17

ICPC

Foot/toe symptom/complaint

2.8

307.7

2944

14344

M79.6

ICD-10 Finland

Pain in limb

5.9

307.7

4777

18054

M79.0

ICD-10 Finland

Rheumatism, unspecified

48.0

307.7

591

134

R52.9

ICD-10 Finland

Pain, unspecified

3.8

307.7

1180

3570

L13

ICPC

Hip symptom/complaint

5.6

307.7

3214

9126

M48.0

ICD-10 Finland

Spinal stenosis

5.1

307.7

1647

3972

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.9

307.7

1416

4306

A02BC05

ATC

esomeprazole; systemic

2.6

307.7

3704

20694

A01

ICPC

Pain general/multiple sites

3.9

307.7

1194

3486

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.7

303.6

2232

10236

N02BF02

ATC

pregabalin; oral

4.5

303.1

818

2016

A02BC03

ATC

lansoprazole; oral

2.6

294.8

2594

12956

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.9

292.0

1819

7637

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

289.3

2518

12490

H02AB06

ATC

prednisolone; systemic

2.4

282.7

3961

24292

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.7

282.3

2113

9724

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.2

280.4

1334

4808

M02AA07

ATC

piroxicam; topical

2.4

275.2

3132

17472

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

6.0

274.8

511

912

NFM20

NOMESCO Finland

Excision of bursa of hip or thigh

+∞

273.7

261

M01AE02

ATC

naproxen; oral, rectal

2.4

273.2

4498

29434

M77.1

ICD-10 Finland

Lateral epicondylitis

4.3

267.4

740

1854

M54.2

ICD-10 Finland

Cervicalgia

3.9

266.0

850

2366

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

265.8

2582

13373

R03AC02

ATC

salbutamol; inhalant

2.4

262.9

4491

29651

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

4.0

262.1

804

2173

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

5.0

261.7

603

1304

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.8

260.1

498

913

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.2

258.9

750

1943

M01AH02

ATC

rofecoxib; oral

3.1

258.3

1273

4667

M54.1

ICD-10 Finland

Radiculopathy

5.7

257.0

501

934

R52.2

ICD-10 Finland

Other chronic pain

6.1

256.3

466

813

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.7

255.1

882

2590

R06.0

ICD-10 Finland

Dyspnoea

2.4

254.0

2406

12273

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

16.4

249.8

212

133

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

11.8

248.8

256

224

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.0

246.8

1301

4946

L28

ICPC

Limited function/disability (L)

2.6

246.6

1838

8365

M03BC51

ATC

orphenadrine, combinations; systemic

2.4

244.5

2385

12288

M47.82

ICD-10 Finland

Other spondylosis, cervical region

5.3

244.4

513

1022

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

9.8

243.7

287

305

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.9

240.7

558

1211

NBG10

NOMESCO Finland

Acromioplastia

22.4

238.3

175

A02BC01

ATC

omeprazole; systemic

2.4

238.1

2363

12242

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.9

237.5

442

788

L86

ICPC

Back syndrome with radiating pain

4.0

234.6

727

1974

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.1

232.5

1143

4168

ZXA00

NOMESCO Finland

Right side

2.4

232.2

2234

11394

M01AX17

ATC

nimesulide; oral

2.4

232.0

2089

10344

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.4

231.5

2204

11188

N02BE01

ATC

paracetamol; systemic, rectal

5.8

225.2

6877

57880

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.9

225.0

710

1951

M01AE03

ATC

ketoprofen; systemic, rectal

2.2

221.9

2971

17339

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

221.9

1754

8159

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

219.3

2452

13280

S18

ICPC

Laceration/cut

2.2

216.8

3760

24225

UJF32

NOMESCO Finland

Coloscopy

2.3

216.5

2302

12195

M47.9

ICD-10 Finland

Spondylosis, unspecified

5.9

214.4

400

714

M77.4

ICD-10 Finland

Metatarsalgia

4.2

212.2

596

1503

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.3

207.9

892

2992

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

3.4

205.0

804

2550

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.5

204.8

783

2443

N06AX16

ATC

venlafaxine; oral

2.7

204.2

1296

5396

L15

ICPC

Knee symptom/complaint

2.3

203.1

2269

12212

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.6

201.0

712

2113

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.1

200.3

975

3518

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.2

199.8

2381

13139

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

4.8

199.8

467

1018

M54.6

ICD-10 Finland

Pain in thoracic spine

3.5

199.4

757

2350

R42

ICD-10 Finland

Dizziness and giddiness

2.3

199.0

2072

10816

R4110

NOMESCO Finland

Physiotherapy

2.2

198.6

2383

13181

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

10.0

198.4

228

234

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.4

197.7

1664

7916

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

3.3

196.2

803

2613

Z3226

NOMESCO Finland

Physiotherapist

2.5

195.5

1543

7124

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

6.0

195.5

353

610

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

193.0

1513

6960

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

192.4

3722

24592

L12

ICPC

Hand/finger symptom/complaint

2.5

192.3

1499

6877

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

191.3

1919

9837

M43.1

ICD-10 Finland

Spondylolisthesis

4.5

191.2

496

1175

M54

ICD-10 Finland

Dorsalgia

2.8

189.3

1139

4601

N06AX11

ATC

mirtazapine; oral

2.1

189.1

2860

17227

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

8.1

188.2

256

326

M65.3

ICD-10 Finland

Trigger finger

5.8

187.7

353

634

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.9

186.1

1008

3850

J01DB01

ATC

cefalexin; oral

2.7

185.5

6163

49932

ZXA05

NOMESCO Finland

Left side

2.2

185.3

2015

10658

A02BA02

ATC

ranitidine; systemic

2.4

183.7

1614

7798

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

22.4

182.6

134

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

5.6

181.6

357

668

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

179.9

3656

24378

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

6.3

179.8

309

508

M02AA10

ATC

ketoprofen; topical

2.4

178.3

1429

6616

J01AA02

ATC

doxycycline; systemic

2.5

175.4

5965

47981

R01AD09

ATC

mometasone; nasal

2.0

175.2

3567

23723

M01AB55

ATC

diclofenac, combinations; oral

3.5

173.1

654

2018

M01AX05

ATC

glucosamine; oral

2.3

172.4

1755

8997

Z71.8

ICD-10 Finland

Other specified counselling

2.0

172.2

2790

17088

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

24.7

168.6

119

L01

ICPC

Neck symptom/complaint

2.4

167.4

1442

6877

R03DC03

ATC

montelukast; oral

2.4

165.9

1462

7038

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

11.2

165.9

176

161

M67.4

ICD-10 Finland

Ganglion

4.0

163.6

485

1268

G57.1

ICD-10 Finland

Meralgia paraesthetica

7.9

163.5

227

296

R07.3

ICD-10 Finland

Other chest pain

2.8

162.5

937

3685

G54.0

ICD-10 Finland

Brachial plexus disorders

6.6

162.1

266

417

R53

ICD-10 Finland

Malaise and fatigue

2.1

160.3

2041

11382

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

25.3

160.0

112

P01AB01

ATC

metronidazole; oral, rectal

1.9

158.7

3286

21737

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

12.0

158.2

160

136

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.4

157.7

1331

6274

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

155.8

1666

8668

R02

ICPC

Shortness of breath/dyspnoea

2.4

154.6

1210

5512

R60.0

ICD-10 Finland

Localized oedema

2.5

154.2

1115

4897

J01MA02

ATC

ciprofloxacin; systemic

2.0

154.1

2890

18440

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

153.9

2485

15062

N01

ICPC

Headache

2.7

153.1

916

3666

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

7.2

152.2

230

330

D01

ICPC

Abdominal pain/cramps general

2.5

152.0

1099

4824

R05

ICPC

Cough

2.1

151.8

2101

12042

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.0

151.8

715

2515

J02AC01

ATC

fluconazole; systemic

1.9

151.5

3428

23239

G47.3

ICD-10 Finland

Sleep apnoea

2.2

151.0

1656

8690

X58

ICD-10 Finland

Exposure to other specified factors

2.5

150.4

1105

4884

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.0

150.4

2233

13118

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

8.6

149.7

193

230

J01FA06

ATC

roxithromycin; oral

1.9

149.7

3091

20311

M35.7

ICD-10 Finland

Hypermobility syndrome

9.8

148.0

172

179

L02

ICPC

Back symptom/complaint

2.6

147.7

933

3834

M54.8

ICD-10 Finland

Other dorsalgia

3.8

147.6

480

1338

J01FA10

ATC

azithromycin; systemic

1.9

147.5

4301

31547

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.7

147.5

901

3641

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.4

146.8

1207

5610

H02BX01

ATC

methylprednisolone, combinations; systemic

3.7

146.2

500

1442

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

144.0

1138

5194

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

143.8

5244

41266

N05CF01

ATC

zopiclone; oral

1.9

142.8

2563

16015

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.6

142.8

938

3926

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

16.2

142.2

121

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.8

142.0

808

3145

H02AB04

ATC

methylprednisolone; systemic

2.3

139.7

1234

5907

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

139.4

1371

6863

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.7

138.9

837

3354

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

5.1

138.9

303

621

WX320

NOMESCO Finland

Spinalanesthesy

2.0

138.3

1944

11142

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

138.1

3060

20415

K30

ICD-10 Finland

Functional dyspepsia

2.4

137.2

1038

4637

E66.01

ICD-10 Finland

Obesity due to excess calories

2.7

137.2

810

3211

N02AJ13

ATC

tramadol and paracetamol; systemic

5.6

135.5

264

489

WX002

NOMESCO Finland

Sedation and analgesia

2.1

133.3

1554

8301

R05

ICD-10 Finland

Cough

2.0

132.3

1790

10098

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

7.6

132.1

189

255

R06AE07

ATC

cetirizine; oral

1.8

131.0

3422

23897

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

3.2

129.9

555

1839

J01FF01

ATC

clindamycin; systemic

2.0

129.8

2011

11881

L87

ICPC

Bursitis/tendinitis/synovitis NOS

6.7

129.4

209

322

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

129.1

3660

26158

L14

ICPC

Leg/thigh symptom/complaint

2.8

128.9

727

2811

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.6

128.6

859

3615

ACC51

NOMESCO Finland

Release of median nerve

2.9

128.3

642

2329

K59.09

ICD-10 Finland

Constipation, unspecified

2.9

127.4

630

2270

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

127.1

2194

13425

AA1AD

NOMESCO Finland

CT of head and brain

1.9

125.9

2177

13319

D06

ICPC

Abdominal pain localized other

2.6

124.6

822

3436

R01BA52

ATC

pseudoephedrine, combinations; oral

1.9

124.3

2461

15713

R74

ICPC

Upper respiratory infection acute

1.9

123.7

2380

15055

Z01.2

ICD-10 Finland

Dental examination

1.8

123.5

3499

24885

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

122.9

5182

41503

L16

ICPC

Ankle symptom/complaint

2.4

122.8

977

4450

R52.1

ICD-10 Finland

Chronic intractable pain

11.4

122.7

128

114

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

4.7

122.5

291

640

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

122.5

2678

17613

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

122.2

4026

29892

R4110, ,

SPAT

2.2

122.1

1206

6017

N06AA10

ATC

nortriptyline; systemic

5.8

121.9

227

403

J01FA09

ATC

clarithromycin; systemic

1.9

121.9

2388

15176

M01AC01

ATC

piroxicam; systemic, rectal

2.3

121.0

1084

5194

M01AB08

ATC

etodolac; oral

2.9

120.9

635

2362

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.5

120.8

439

1315

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

120.6

3343

23566

J45

ICD-10 Finland

Asthma

2.4

120.6

945

4274

R03BA02

ATC

budesonide; inhalant

2.1

120.5

1449

7796

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.6

120.4

774

3192

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.5

120.4

302

694

M76.6

ICD-10 Finland

Achilles tendinitis

3.8

120.2

376

1018

J01DA01

ATC

[U] cefalexin

1.8

120.2

4448

34103

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

120.1

1508

8243

M77.9

ICD-10 Finland

Enthesopathy, unspecified

4.7

119.9

288

639

R01AD08

ATC

fluticasone; nasal

1.9

119.8

2176

13485

B01AB05

ATC

enoxaparin; parenteral

1.8

119.8

2456

15811

WZA90

NOMESCO Finland

Other medical or dental certificate

2.0

119.5

1760

10175

M13.9

ICD-10 Finland

Arthritis, unspecified

2.9

119.4

608

2224

N04BC05

ATC

pramipexole; oral

2.7

119.3

680

2640

R03AK07

ATC

formoterol and budesonide; inhalant

2.0

119.3

1664

9440

A97

ICPC

No disease

2.0

119.2

1646

9305

S29

ICPC

Skin symptom/complaint other

2.0

118.9

1687

9626

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.9

118.8

587

2112

M76.3

ICD-10 Finland

Iliotibial band syndrome

13.8

118.5

110

J01EA01

ATC

trimethoprim; systemic

1.9

118.4

2254

14167

K07.60

ICD-10 Finland

Snapping jaw

3.3

117.7

458

1432

NBL05

NOMESCO Finland

Arthroscopic suture or reinsertation of rotator cuff of shoulder

11.6

117.2

121

106

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

117.1

1669

9531

R5599

NOMESCO Finland

Other rehabilitation service

4.7

117.1

279

615

H01

ICPC

Ear pain/earache

2.3

116.8

970

4496

M01AE01

ATC

ibuprofen; systemic, rectal

2.6

116.7

6515

57085

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.7

116.6

388

1096

G04BD12

ATC

mirabegron; oral

2.3

116.6

1055

5072

NE1BG, ,

SPAT

5.4

116.2

235

450

R01AD58

ATC

fluticasone, combinations; nasal

1.9

115.7

1878

11199

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

5.4

115.7

232

441

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.1

115.5

521

1780

R96

ICPC

Asthma

2.4

115.3

892

4007

M70.8

ICD-10 Finland

Other soft tissue disorders related to use, overuse and pressure

11.0

114.8

123

114

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

114.8

2832

19213

D11

ICPC

Diarrhoea

2.3

114.7

953

4417

L04AX03

ATC

methotrexate; systemic

2.5

114.2

833

3643

M50.3

ICD-10 Finland

Other cervical disc degeneration

5.1

114.0

245

495

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.3

112.9

302

729

C07AB07

ATC

bisoprolol; oral

1.7

112.8

3557

25843

R06AX27

ATC

desloratadine; oral

1.8

112.7

2181

13739

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.2

112.4

1040

5041

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

112.2

959

4496

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

3.7

112.2

365

1015

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.6

111.4

711

2918

N30.0

ICD-10 Finland

Acute cystitis

2.0

111.4

1579

8981

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

111.3

963

4537

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

5.7

110.5

210

380

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

110.3

1263

6651

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

110.2

3700

27291

A11

ICPC

Chest pain NOS

2.5

109.9

747

3159

S80.0

ICD-10 Finland

Contusion of knee

2.7

109.7

656

2606

A02BC04

ATC

rabeprazole; oral

2.5

109.7

745

3149

L29

ICPC

Musculoskeletal sympt/complt other

2.5

109.5

778

3359

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

8.1

109.4

148

187

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

5.1

109.3

235

475

R52.0

ICD-10 Finland

Acute pain

4.1

109.1

312

792

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

10.2

108.9

123

R03BA05

ATC

fluticasone; inhalant

2.0

108.9

1398

7673

M01AX01

ATC

nabumetone; oral

3.5

108.7

396

1187

P01BA02

ATC

hydroxychloroquine; oral

2.5

108.5

741

3139

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

6.9

107.8

168

249

M19.8

ICD-10 Finland

Other specified arthrosis

3.4

107.5

405

1240

N17

ICPC

Vertigo/dizziness

2.2

107.4

1115

5651

M75.5

ICD-10 Finland

Bursitis of shoulder

5.0

107.3

233

475

M15

ICD-10 Finland

Polyarthrosis

2.9

107.2

536

1938

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

4.4

106.6

278

658

NFM10

NOMESCO Finland

Fasciotomy of thigh

51.3

106.0

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

105.5

1081

5447

R03AC03

ATC

terbutaline; inhalant

2.1

104.7

1126

5780

M75.2

ICD-10 Finland

Bicipital tendinitis

5.3

104.7

216

421

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

104.6

1374

7590

SAA02

NOMESCO Finland

Basic examination of mouth

1.8

104.4

4720

37557

J01CA04

ATC

amoxicillin; systemic

2.0

104.0

5850

49704

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.5

103.9

380

1141

ZXD20

NOMESCO Finland

Day surgery

2.2

103.7

1000

4918

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.5

103.6

259

593

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.2

103.6

943

4530

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.4

103.1

765

3365

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

102.6

2335

15350

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

13.1

102.4

R4120

NOMESCO Finland

Occupational therapy

2.9

102.4

524

1918

SFA10

NOMESCO Finland

One-surface restoration

1.7

101.4

3906

29639

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

101.3

823

3766

N03AE01

ATC

clonazepam; systemic

3.0

101.0

475

1659

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.7

100.8

327

907

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.3

100.7

393

1229

M01AH03

ATC

valdecoxib; oral

2.9

100.6

504

1823

SPAT1153

SPAT

Removal of sutures

1.8

100.6

2228

14515

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.4

99.7

793

3594

M77.0

ICD-10 Finland

Medial epicondylitis

5.1

99.7

214

432

M75.8

ICD-10 Finland

Other shoulder lesions

3.7

99.5

323

896

N02AA05

ATC

oxycodone; systemic

2.0

99.5

1378

7741

U02

ICPC

Urinary frequency/urgency

2.0

99.3

1344

7488

C03CA01

ATC

furosemide; systemic

1.8

99.2

2099

13484

N05BA01

ATC

diazepam; systemic, rectal

2.2

99.1

1007

5049

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

98.7

1627

9679

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.6

98.6

616

2497

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.7

98.4

559

2160

D19

ICPC

Teeth/gum symptom/complaint

1.8

98.1

2305

15251

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

7.1

98.0

148

212

R01AD12

ATC

fluticasone furoate; nasal

1.8

97.6

2255

14845

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.5

97.1

644

2686

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

97.1

2910

20574

A03FA02

ATC

cisapride; oral, rectal

2.6

96.9

629

2596

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.9

96.8

482

1737

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

5.1

96.4

206

414

R03BA01

ATC

beclometasone; inhalant

2.1

96.4

1118

5891

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

96.0

1819

11286

R21

ICPC

Throat symptom/complaint

1.9

95.8

1455

8418

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.5

95.7

684

2954

M19.9

ICD-10 Finland

Arthrosis, unspecified

3.1

95.5

423

1427

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.1

95.2

997

5053

SFA20

NOMESCO Finland

Two-surface restoration

1.7

95.1

4138

32187

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

94.9

1333

7510

NF1AA, ,

SPAT

2.9

94.6

458

1625

E66.8

ICD-10 Finland

Other obesity

2.9

94.5

468

1681

ZXE00

NOMESCO Finland

One hour or less

1.7

94.5

2722

19003

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

94.2

510

1921

L05

ICPC

Flank/axilla symptom/complaint

2.7

93.5

542

2115

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.8

93.5

1784

11080

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

93.1

597

2449

R13

ICD-10 Finland

Dysphagia

2.6

92.8

573

2307

K02.1

ICD-10 Finland

Caries of dentine

1.7

92.8

4042

31360

UKC02

NOMESCO Finland

Cystoscopy

2.1

92.6

984

5011

Z3231

NOMESCO Finland

Registered nurse

1.8

92.1

1923

12256

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

5.4

91.9

182

342

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.6

91.8

222

495

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

91.7

1167

6348

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.1

91.6

941

4730

R05FA02

ATC

opium derivatives and expectorants; systemic

1.7

91.6

2935

21025

R51

ICD-10 Finland

Headache

2.9

91.5

457

1649

Z2221

NOMESCO Finland

Medical doctor

1.8

91.3

2003

12944

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

90.9

875

4287

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

4.5

90.5

227

521

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.3

90.1

346

1071

H57.1

ICD-10 Finland

Ocular pain

3.4

89.9

342

1052

P06

ICPC

Sleep disturbance

2.1

89.7

970

4970

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

5.0

89.3

196

403

N05AH04

ATC

quetiapine; oral

2.0

89.3

1214

6751

M02AA15

ATC

diclofenac; topical

2.5

89.1

611

2585

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

29.7

89.1

R5110, ,

SPAT

2.3

88.9

775

3644

R12

ICD-10 Finland

Heartburn

2.3

88.9

713

3237

C10AX09

ATC

ezetimibe; oral

1.9

88.7

1236

6930

N05BA04

ATC

oxazepam; oral

1.7

88.7

2001

13015

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

5.8

88.4

164

290

XA402

NOMESCO Finland

ENMG

4.5

87.6

215

485

H92.0

ICD-10 Finland

Otalgia

2.6

87.5

527

2094

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

43.6

87.1

R05FB02

ATC

cough suppressants and expectorants; systemic

1.7

87.0

2760

19643

F51.0

ICD-10 Finland

Nonorganic insomnia

1.9

86.7

1250

7083

S21

ICPC

Skin texture symptom/complaint

1.9

86.5

1199

6706

E0000UV, ,

ATC

1.6

86.4

3069

22465

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

86.0

541

2196

A07EC01

ATC

sulfasalazine; oral, rectal

2.5

85.9

606

2596

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.5

85.7

304

894

N03AX09

ATC

lamotrigine; oral

3.2

85.6

359

1172

WX200

NOMESCO Finland

Interscalenous plexus blockade

5.5

85.4

167

310

U07

ICPC

Urine symptom/complaint other

2.3

85.0

740

3475

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

84.8

626

2737

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

3.6

84.8

289

828

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

84.7

2182

14682

L11

ICPC

Wrist symptom/complaint

2.3

84.6

740

3481

J01DA09

ATC

[U] cefadroxil

1.7

84.4

1842

11842

N06AB04

ATC

citalopram; systemic

1.8

83.6

1567

9632

Z50.1

ICD-10 Finland

Other physical therapy

2.9

83.6

425

1547

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.9

83.5

422

1531

C07AA05

ATC

propranolol; systemic

1.8

83.5

1515

9224

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.2

83.5

748

3554

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.7

83.3

2243

15258

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

83.3

549

2278

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

83.3

537

2205

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

3.5

83.2

291

848

L20

ICPC

Joint symptom/complaint NOS

3.1

82.7

357

1185

M66.0

ICD-10 Finland

Rupture of popliteal cyst

10.8

82.7

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.4

82.6

314

965

TQW40, ,

SPAT

2.2

82.4

813

4014

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

5.8

82.3

151

264

H02AB07

ATC

prednisone; oral

2.0

81.6

1017

5474

L60.0

ICD-10 Finland

Ingrowing nail

2.9

81.5

394

1395

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

5.3

80.7

165

319

R09

ICPC

Sinus symptom/complaint

2.3

80.5

657

3000

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.1

80.5

827

4145

M15.8

ICD-10 Finland

Other polyarthrosis

4.0

80.4

237

614

7265A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of hip region[BURSITIS TROCHANTERICA]

+∞

80.3

G43.9

ICD-10 Finland

Migraine, unspecified

2.7

80.2

465

1812

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

10.3

80.0

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

79.8

990

5316

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

79.8

1003

5411

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

10.6

79.6

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

79.5

3106

23122

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

79.3

1532

9484

A04

ICPC

Weakness/tiredness general

1.9

78.9

1186

6794

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

78.8

1004

5440

WX290

NOMESCO Finland

Other blockage of nerve

1.6

78.8

3086

22968

N02AC04

ATC

dextropropoxyphene; oral

3.6

78.8

270

776

D07AC01

ATC

betamethasone; topical

1.6

78.7

2602

18588

R03BA08

ATC

ciclesonide; inhalant

2.2

78.1

701

3329

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

3.6

78.1

261

738

NA3BG, ,

SPAT

3.1

78.1

349

1182

A06AD11

ATC

lactulose; oral

2.0

77.8

1027

5633

A02BA04

ATC

nizatidine; systemic

2.4

77.8

576

2520

ZXA10

NOMESCO Finland

Bilateral

1.8

77.7

1397

8458

J05AB01

ATC

aciclovir; systemic

1.7

77.6

1691

10826

G57.6

ICD-10 Finland

Lesion of plantar nerve

4.2

77.5

208

503

A28

ICPC

Limited function/disability NOS

1.8

77.4

1353

8121

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

77.4

2653

19100

9242

FHL

Other reconstruction or plastic surgery of shoulder joint (including ac joint)

10.4

77.4

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

37.2

77.2

J31.0

ICD-10 Finland

Chronic rhinitis

2.3

77.2

661

3078

N05CF02

ATC

zolpidem; oral

1.8

77.0

1328

7937

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

76.9

747

3661

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

11.6

76.6

N06AB10

ATC

escitalopram; oral

1.8

76.0

1427

8746

A08

ICPC

Swelling

2.5

76.0

508

2120

C10AA07

ATC

rosuvastatin; oral

1.6

76.0

2534

18102

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

75.9

608

2752

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

75.4

593

2663

SFA30

NOMESCO Finland

Three-surface restoration

1.6

74.9

3030

22642

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.0

74.7

344

1185

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.0

74.6

351

1223

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

74.6

460

1847

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

4.8

74.5

172

369

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.8

74.4

398

1487

M01AE52

ATC

naproxen and esomeprazole; oral

3.3

74.3

289

901

C10AA05

ATC

atorvastatin; oral

1.6

74.2

2978

22195

K10.3

ICD-10 Finland

Alveolitis of jaws

2.9

74.0

359

1273

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.0

73.8

957

5210

J01

ICD-10 Finland

Acute sinusitis

2.6

73.3

462

1874

R35

ICD-10 Finland

Polyuria

2.6

73.1

460

1865

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.0

72.4

341

1189

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

72.4

1655

10706

K08.80

ICD-10 Finland

Toothache NOS

2.2

72.3

690

3354

U01

ICPC

Dysuria/painful urination

2.2

72.3

705

3457

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.2

72.2

638

3007

M09AX01

ATC

hyaluronic acid; parenteral

2.8

71.9

382

1422

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.7

71.8

407

1566

S70.0

ICD-10 Finland

Contusion of hip

3.1

71.5

311

1036

SPAT1260

SPAT

Consultation of another employee

1.8

71.1

1245

7458

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.9

71.0

340

1196

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.6

70.6

4484

36922

L18

ICPC

Muscle pain

2.9

70.4

351

1263

N06AB03

ATC

fluoxetine; oral

2.0

70.1

926

5068

J20

ICD-10 Finland

Acute bronchitis

2.0

70.0

803

4182

R06AX22

ATC

ebastine; oral

1.8

70.0

1296

7890

F45.8

ICD-10 Finland

Other somatoform disorders

2.5

69.5

484

2056

N05CD07

ATC

temazepam; oral

2.0

69.0

839

4460

J46

ICD-10 Finland

Status asthmaticus

3.4

68.9

258

785

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

6.4

68.9

114

180

S22.3

ICD-10 Finland

Fracture of rib

2.5

68.7

476

2018

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.7

68.6

224

623

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

68.6

1181

7032

Z71.9

ICD-10 Finland

Counselling, unspecified

2.2

68.6

645

3115

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.4

68.1

249

746

R11

ICD-10 Finland

Nausea and vomiting

2.1

68.1

664

3252

R07.0

ICD-10 Finland

Pain in throat

2.4

67.8

516

2281

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.1

67.7

749

3848

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

67.7

862

4656

S06.0

ICD-10 Finland

Concussion

2.1

67.6

735

3751

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

8.4

67.6

106

M45

ICD-10 Finland

Ankylosing spondylitis

4.5

67.3

164

368

M71.9

ICD-10 Finland

Bursopathy, unspecified

7.0

67.2

102

147

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

7.1

67.2

101

144

M25.2

ICD-10 Finland

Flail joint

7.4

66.8

133

SPAT1336

SPAT

Request for examination

3.0

66.6

312

1084

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

14.4

66.4

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

4.3

66.4

173

409

D02

ICPC

Abdominal pain epigastric

2.3

66.3

515

2296

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.8

66.2

346

1276

F29

ICPC

Eye symptom/complaint other

2.0

66.1

832

4474

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

65.9

540

2463

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.1

65.9

285

946

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.2

65.7

594

2822

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

65.6

1500

9668

P03

ICPC

Feeling depressed

2.1

65.5

648

3190

Z01.7

ICD-10 Finland

Laboratory examination

1.8

64.9

1262

7774

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

64.9

2562

18858

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.3

64.7

500

2224

A03

ICPC

Fever

1.8

64.7

1117

6646

R83

ICPC

Respiratory infection other

1.7

64.6

1655

10984

M22.4

ICD-10 Finland

Chondromalacia patellae

3.7

64.5

210

583

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

4.3

64.4

166

389

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

5.7

64.4

120

213

WZC00, ,

SPAT

1.8

64.4

1084

6399

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

64.3

4379

36234

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.3

64.2

512

2308

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

64.1

1284

7975

SPAT1263

SPAT

Sampling

1.5

63.7

2766

20771

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

7.4

63.4

126

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

3.2

63.4

254

806

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.1

63.4

177

441

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.3

63.4

522

2386

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

63.2

1339

8443

L04

ICPC

Chest symptom/complaint

2.3

63.2

508

2298

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

63.2

1764

11954

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

63.0

984

5673

TNB11, ,

SPAT

9.7

62.7

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

+∞

62.6

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

62.5

942

5369

M79.8

ICD-10 Finland

Other specified soft tissue disorders

14.5

62.1

M66.4

ICD-10 Finland

Spontaneous rupture of other tendons

24.6

62.1

Z00.0

ICD-10 Finland

General medical examination

1.7

61.8

1297

8151

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.5

61.7

218

639

N39.3

ICD-10 Finland

Stress incontinence

2.0

61.6

704

3653

M24.8

ICD-10 Finland

Other specific joint derangements, not elsewhere classified

9.1

61.6

M23.8

ICD-10 Finland

Other internal derangements of knee

3.1

61.5

271

909

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

61.5

495

2239

EB1AA, ,

SPAT

2.2

61.5

529

2461

G50.1

ICD-10 Finland

Atypical facial pain

4.2

61.0

164

397

A03CA02

ATC

clidinium and psycholeptics; oral

2.4

60.9

446

1937

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

60.9

537

2524

J01CA08

ATC

pivmecillinam; oral

1.5

60.8

3487

27683

R51.81

ICD-10 Finland

Facial pain NOS

3.5

60.7

216

636

L89

ICPC

Osteoarthrosis of hip

2.7

60.6

347

1341

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

4.8

60.6

138

293

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

60.5

1518

9997

SPAT1283

SPAT

Restricted health certificate

1.8

60.4

966

5605

A01AB09

ATC

miconazole; local oral

2.1

60.2

653

3324

S01

ICPC

Pain/tenderness of skin

2.6

60.2

369

1475

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

59.9

370

1484

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

59.9

1821

12571

M75

ICD-10 Finland

Shoulder lesions

2.7

59.9

333

1268

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.6

59.8

377

1527

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

59.5

661

3394

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.3

59.5

233

729

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.7

59.5

334

1278

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.3

59.3

225

690

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

59.2

1932

13555

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

59.2

2587

19368

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.2

59.0

246

799

NF1DA

NOMESCO Finland

X-ray of hips

3.7

59.0

193

538

D07AC13

ATC

mometasone; topical

1.6

58.9

1978

13966

G04BD08

ATC

solifenacin; oral

2.2

58.9

510

2378

SPAT1301

SPAT

No procedures

1.6

58.5

2079

14864

9473

FHL

Local soft tissue removal or exploration (eg Bursa)

11.6

58.5

C08CA01

ATC

amlodipine; oral

1.5

58.5

2685

20300

N06AX26

ATC

vortioxetine; oral

2.2

58.3

524

2480

J01FA15

ATC

telithromycin; oral

2.0

58.2

713

3790

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

57.9

2163

15632

A99

ICPC

Disease/condition unspecnature/site

1.9

57.9

778

4267

A29

ICPC

General symptom/complaint other

1.8

57.9

981

5790

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.4

57.7

213

642

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

57.6

443

1965

R25.2

ICD-10 Finland

Cramp and spasm

3.5

57.4

199

576

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

11.9

57.4

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

57.4

340

1336

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.7

57.4

186

515

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

57.3

649

3354

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.2

57.2

234

752

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

4.8

57.1

129

272

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

57.0

1189

7445

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

56.7

901

5211

N06AX12

ATC

bupropion; oral

2.3

56.7

447

2003

S22

ICPC

Nail symptom/complaint

2.2

56.6

506

2390

XKD00

NOMESCO Finland

Uroflowmetry

2.0

56.5

649

3371

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

56.4

1121

6924

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

56.3

1584

10707

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

56.3

632

3256

R00.2

ICD-10 Finland

Palpitations

2.0

56.3

623

3193

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

6.3

56.2

150

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.5

56.0

193

557

M70.9

ICD-10 Finland

Unspecified soft tissue disorder related to use, overuse and pressure

7.8

55.6

100

SFA00

NOMESCO Finland

Small restoration

1.8

55.5

994

5957

M19

ICD-10 Finland

Other arthrosis

3.3

55.1

209

641

J01MA12

ATC

levofloxacin; systemic

1.7

54.9

1182

7456

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

17.4

54.9

R03AC13

ATC

formoterol; inhalant

2.5

54.7

374

1573

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

54.7

675

3593

L84

ICPC

Back syndrome without radiat pain

2.5

54.7

370

1549

L10

ICPC

Elbow symptom/complaint

2.5

54.6

364

1514

K59.0

ICD-10 Finland

Constipation

2.3

54.4

419

1859

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.9

54.3

254

882

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

54.2

451

2067

C05AA08

ATC

fluocortolone; rectal, topical

1.8

54.1

945

5619

L88

ICPC

Rheumatoid/seropositive arthritis

2.5

54.1

347

1417

N03AF01

ATC

carbamazepine; oral, rectal

2.5

53.9

348

1425

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

53.9

902

5296

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

4.1

53.9

150

373

M89.0

ICD-10 Finland

Algoneurodystrophy

7.6

53.8

101

H02.3

ICD-10 Finland

Blepharochalasis

2.1

53.7

544

2697

L09

ICPC

Arm symptom/complaint

2.4

53.6

367

1545

XF402

NOMESCO Finland

ECG with work load test

1.9

53.4

685

3695

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.4

53.4

379

1622

WX402

NOMESCO Finland

General anaesthesia

1.6

53.0

1548

10538

NE1AA, ,

SPAT

3.6

52.7

176

497

NA3AA, ,

SPAT

2.6

52.7

316

1249

J01DA06

ATC

[U] cefuroxime

1.8

52.7

971

5862

N06AB06

ATC

sertraline; oral

1.9

52.7

760

4260

SPAT1229

SPAT

Assessment of need for aid

2.1

52.5

543

2711

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.8

52.5

262

942

SGA01

NOMESCO Finland

Emergency treatment

1.7

52.4

1016

6220

SPAT1312

SPAT

General health counselling

1.5

52.2

2037

14793

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.7

52.2

172

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

+∞

52.1

73109

ICD-8 Finland

Synovitis, bursitis and tenosynovitis, Unspecified

+∞

52.1

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

10.4

51.7

TQW40

NOMESCO Finland

Remowal of suture of skin

2.1

51.7

500

2434

K03.80

ICD-10 Finland

Irradiated enamel

2.3

51.7

424

1932

A01AB04

ATC

amphotericin B; local oral

2.4

51.6

384

1678

R55

ICD-10 Finland

Syncope and collapse

1.9

51.5

725

4029

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.1

51.5

533

2662

C01CA24

ATC

epinephrine; parenteral

2.2

51.4

437

2020

M43.0

ICD-10 Finland

Spondylolysis

4.2

51.4

138

334

K80

ICPC

Cardiac arrhythmia NOS

1.9

51.2

669

3629

D07AD01

ATC

clobetasol; topical

1.6

51.2

1263

8243

NCL22

NOMESCO Finland

Myotomy or tenotomy of elbow or forearm

262.5

51.2

A46

ICD-10 Finland

Erysipelas

1.8

51.1

917

5490

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

51.0

738

4138

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

51.0

884

5239

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

51.0

378

1649

C09CA06

ATC

candesartan; oral

1.6

50.7

1752

12378

R75

ICPC

Sinusitis acute/chronic

2.4

50.7

362

1553

M01AB01

ATC

indometacin; systemic, rectal

2.3

50.7

419

1915

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.4

50.6

380

1666

ACC53

NOMESCO Finland

Release of ulnar nerve

5.5

50.6

177

R01AD01

ATC

beclometasone; nasal

1.7

50.6

1061

6634

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

50.5

535

2694

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

50.5

335

1389

XQ800

NOMESCO Finland

Prick test

2.1

50.5

497

2435

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

50.4

1052

6567

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

50.4

700

3873

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

9.2

50.4

9476

FHL

Splitting of fascia or aponeurosis

10.9

50.4

M03BX01

ATC

baclofen; systemic

3.9

50.2

149

388

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

50.2

1852

13270

M77.8

ICD-10 Finland

Other enthesopathies, not elsewhere classified

7.8

50.1

P01

ICPC

Feeling anxious/nervous/tense

1.9

50.0

710

3955

W19

ICD-10 Finland

Unspecified fall

1.9

50.0

664

3619

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.4

50.0

362

1562

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

49.9

432

2012

T78.4

ICD-10 Finland

Allergy, unspecified

2.5

49.9

332

1379

L84

ICD-10 Finland

Corns and callosities

2.8

49.8

261

963

M62.6

ICD-10 Finland

Muscle strain

3.2

49.7

200

636

SPAT1202

SPAT

Intra-articular injection

2.9

49.7

243

864

N62

ICD-10 Finland

Hypertrophy of breast

2.4

49.7

339

1424

L99

ICPC

Musculoskeletal disease other

3.2

49.5

195

612

A23

ICPC

Risk factor NOS

1.9

49.3

679

3745

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

49.1

1415

9581

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

49.0

750

4278

A07AA02

ATC

nystatin; oral

2.2

48.9

446

2120

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

5.1

48.8

103

205

D09

ICPC

Nausea

2.5

48.8

330

1381

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

48.7

858

5105

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

48.6

1796

12854

J01MA06

ATC

norfloxacin; oral

1.7

48.6

989

6127

B01AC04

ATC

clopidogrel; oral

1.7

48.4

933

5694

R06.5

ICD-10 Finland

Mouth breathing

2.0

48.4

535

2736

WZA00

NOMESCO Finland

Concise certificate

2.2

48.3

438

2077

L01BA01

ATC

methotrexate; systemic

2.6

48.3

286

1123

K04.0

ICD-10 Finland

Pulpitis

2.0

48.2

557

2894

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

48.2

677

3758

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.0

48.1

548

2832

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.1

48.1

135

338

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.8

47.9

247

904

WX110, ,

SPAT

2.2

47.8

426

2006

TAB20

NOMESCO Finland

Epidural puncture

5.7

47.8

158

SCA01

NOMESCO Finland

Preventive oral health care, short

1.5

47.7

1800

12935

NFL30

NOMESCO Finland

Transposition of muscle of hip or thigh

5.5

47.7

169

R03BB04

ATC

tiotropium bromide; inhalant

1.9

47.6

619

3350

U05

ICPC

Urination problems other

2.3

47.5

374

1674

C01DA14

ATC

isosorbide mononitrate; oral

1.8

47.1

835

4974

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.3

47.0

363

1611

N30

ICD-10 Finland

Cystitis

1.9

46.9

687

3862

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

7.6

46.6

M20.2

ICD-10 Finland

Hallux rigidus

2.7

46.6

248

923

EB1VA, ,

NOMESCO Finland

1.6

46.5

1205

7939

NFF25

NOMESCO Finland

Cleaning of hip joint, arthroscopic

11.5

46.4

U71

ICPC

Cystitis/urinary infection other

1.9

46.4

599

3232

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

46.3

794

4682

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.2

46.3

429

2052

T82

ICPC

Obesity

2.5

46.3

304

1255

SPAT1325

SPAT

Vaccination

1.5

46.2

2198

16539

R10.0

ICD-10 Finland

Acute abdomen

2.8

46.1

239

877

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.7

46.0

251

946

D12

ICPC

Constipation

2.5

46.0

290

1174

C10AA03

ATC

pravastatin; oral

2.1

45.9

485

2438

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.2

45.9

185

589

TNF10

NOMESCO Finland

Puncture of hip joint

14.1

45.9

D82

ICPC

Teeth/gum disease

1.5

45.9

2443

18781

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

45.8

430

2067

NCL99

NOMESCO Finland

Other operation on muscle or tendon of elbow or forearm

100.7

45.8

L04AA13

ATC

[U] leflunomide

3.0

45.6

205

696

SPAT1058

SPAT

PEF monitoring instruction

2.0

45.6

563

2992

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

45.5

361

1620

KMAK, ,

NOMESCO Finland

1.4

45.4

3276

26611

SDA03

NOMESCO Finland

Periodontal treatment

1.4

45.4

2763

21768

H03AA01

ATC

levothyroxine sodium; systemic

1.5

45.3

1841

13409

H29

ICPC

Ear symptom/complaint other

1.7

45.1

880

5383

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.1

45.0

196

653

G04CA02

ATC

tamsulosin; oral

1.8

45.0

745

4347

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.5

44.9

2409

18525

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.2

44.9

176

551

R07

ICPC

Sneezing/nasal congestion

2.1

44.9

425

2050

SPAT1310

SPAT

Counselling related to known health issue

1.5

44.8

2040

15196

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

44.8

356

1599

R50.9

ICD-10 Finland

Fever, unspecified

1.7

44.7

926

5755

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

4.3

44.6

116

274

UJD02

NOMESCO Finland

Gastroscopy

2.3

44.5

333

1457

S83.2

ICD-10 Finland

Tear of meniscus, current

2.2

44.5

407

1936

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

44.5

1371

9400

A02BA03

ATC

famotidine; systemic

2.6

44.1

258

1007

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.6

44.1

262

1031

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.5

44.0

284

1163

7263A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of elbow region[EPICONDYLITIS LATERALIS HUMERI]

+∞

43.8

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

43.7

579

3149

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

43.7

311

1332

S04

ICPC

Lump/swelling localized

1.8

43.6

752

4438

M70.2

ICD-10 Finland

Olecranon bursitis

3.5

43.6

154

452

M19.2

ICD-10 Finland

Other secondary arthrosis

4.6

43.5

102

222

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.6

43.5

258

1014

R30.0

ICD-10 Finland

Dysuria

2.4

43.5

319

1384

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

43.5

332

1466

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.6

43.5

144

405

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

43.5

317

1372

M24.2

ICD-10 Finland

Disorder of ligament

5.0

43.3

188

A98

ICPC

Health maint/preventive medicine

2.7

43.1

6958

66487

L90

ICPC

Osteoarthrosis of knee

2.0

43.1

531

2819

P76

ICPC

Depressive disorder

2.1

43.0

428

2103

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.8

42.9

130

344

N81.6

ICD-10 Finland

Rectocele

1.9

42.9

619

3461

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

42.9

835

5101

L04AB04

ATC

adalimumab; parenteral

3.2

42.6

168

528

K02.0

ICD-10 Finland

Caries limited to enamel

1.6

42.6

1244

8416

N06AX03

ATC

mianserin; oral

2.3

42.6

345

1562

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

42.6

645

3661

E66

ICD-10 Finland

Obesity

2.2

42.5

388

1844

J02AC02

ATC

itraconazole; systemic

1.6

42.5

1250

8470

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

42.4

875

5429

C09CA01

ATC

losartan; oral

1.5

42.3

1806

13253

F01

ICPC

Eye pain

2.7

42.3

227

848

N06AB05

ATC

paroxetine; oral

2.1

42.3

419

2056

R15

ICD-10 Finland

Faecal incontinence

2.5

42.1

261

1048

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

5.7

42.1

138

WZB00, ,

SPAT

1.9

42.0

560

3052

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

2.2

41.9

380

1801

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

41.9

206

735

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

4.5

41.9

101

225

XKC03

NOMESCO Finland

Water cystometry

2.6

41.8

241

934

B01AF01

ATC

rivaroxaban; oral

1.7

41.7

834

5131

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.9

41.6

201

710

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

41.6

1127

7488

R01AD05

ATC

budesonide; nasal

1.9

41.6

533

2866

SPAT1216

SPAT

Assessment of functional ability

1.6

41.6

1024

6648

C10AA01

ATC

simvastatin; oral

1.4

41.5

2660

21048

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.8

41.5

213

778

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

4.4

41.5

103

235

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

41.4

4366

37633

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.8

41.4

125

330

Z2446

NOMESCO Finland

Social worker

2.1

41.3

395

1911

M01AE51

ATC

ibuprofen, combinations; systemic

3.9

41.3

120

308

WX308

NOMESCO Finland

Sacral anesthesy

11.4

41.3

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

41.3

779

4715

SPAT1210

SPAT

Application of cast or individual aid

2.4

41.2

304

1322

C08CA13

ATC

lercanidipine; oral

1.6

40.8

1026

6693

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

40.8

539

2928

NFL20

NOMESCO Finland

Freeing of muscle of hip or thigh

13.6

40.8

S20.2

ICD-10 Finland

Contusion of thorax

2.2

40.7

337

1539

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

3.5

40.7

143

418

R49.01

ICD-10 Finland

Functional dysphonia

2.6

40.6

233

901

R29

ICPC

Respiratory symptom/complaint other

2.0

40.6

463

2392

J01FA01

ATC

erythromycin; systemic

1.7

40.5

847

5271

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

40.4

643

3702

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.9

40.4

536

2914

D07AA02

ATC

hydrocortisone; topical

1.7

40.4

855

5336

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

40.3

2126

16223

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

6.2

40.3

113

G04BD04

ATC

oxybutynin; oral, transdermal

2.1

40.3

384

1856

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

6.6

40.3

N07BA03

ATC

varenicline; oral

2.3

40.2

301

1318

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.8

40.0

207

759

J01MA14

ATC

moxifloxacin; systemic

1.9

40.0

576

3217

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.6

40.0

229

885

M71.3

ICD-10 Finland

Other bursal cyst

13.2

39.9

G56.4

ICD-10 Finland

Causalgia

10.8

39.9

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

39.9

494

2625

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

39.9

686

4042

F34.1

ICD-10 Finland

Dysthymia

2.5

39.8

247

992

K07

ICPC

Swollen ankles/oedema

2.2

39.8

356

1679

N03AX11

ATC

topiramate; oral

3.1

39.7

170

561

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

5.4

39.6

146

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

39.6

1126

7559

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

39.5

1759

12986

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

3.9

39.3

115

297

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

39.3

269

1132

R06AE09

ATC

levocetirizine; oral

1.6

39.2

939

6046

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

39.2

1646

12013

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2512

10819

3.04

307.65

1.5

1.3

31.45

36.62

iu/ml

0.79

754

3405

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2386

9936

3.10

307.65

1.5

1.2

9.42

13.82

u/ml

2.36

914

3868

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

6193

46469

3.47

299.00

6.3

4.0

12.58

13.07

mm/h

2.06

5931

43186

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2424

12327

2.46

258.47

2.0

1.6

0.98

1.30

mg/l

6.82

1925

9612

(3013115) Eosinophils [#/volume] in Blood

4702

32310

2.33

240.97

7.4

6.2

0.19

e9/l

0.59

4051

27775

(3006315) Basophils [#/volume] in Blood

4592

31374

2.29

236.58

7.1

6.0

0.04

e9/l

0.90

3887

26534

(3019198) Lymphocytes [#/volume] in Blood

4640

31970

2.28

232.24

7.2

6.1

1.94

1.90

e9/l

1.34

4020

27735

(3001604) Monocytes [#/volume] in Blood

4569

31289

2.27

232.02

7.1

6.0

0.57

e9/l

0.01

3881

26486

(3021601) Nitrite [Presence] in Urine by Test strip

4737

33040

2.28

228.30

5.3

3.8

0.00

estimate

0.36

833

6717

(3015736) pH of Urine

4029

26365

2.21

227.04

4.6

3.4

6.27

6.25

0.71

2086

14322

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3109

18392

2.22

225.41

2.5

2.0

166.36

195.68

u/l

1.69

2997

17232

(3035350) Ketones [Presence] in Urine by Test strip

4765

33459

2.27

223.74

5.3

3.8

4.64

3.72

estimate

0.13

866

6963

(3009261) Glucose [Presence] in Urine by Test strip

4804

33850

2.27

223.60

5.4

3.8

2.48

0.31

estimate

0.69

830

6633

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6177

48873

2.92

219.43

9.3

8.1

75.93

80.23

u/l

16.40

5968

46199

(3013650) Neutrophils [#/volume] in Blood by Automated count

5000

35975

2.29

218.74

9.3

10.0

4.10

4.04

e9/l

1.13

4284

30888

(3037522) Nuclear Ab [Titer] in Serum

1734

8160

2.48

212.87

1.5

1.3

487.36

558.49

titre

0.78

348

1903

(3011397) Hemoglobin [Presence] in Urine by Test strip

2700

15372

2.21

212.25

4.9

3.7

0.78

0.14

—

187

(3031040) Bacteria [#/volume] in Urine by Automated count

5491

41351

2.41

211.77

6.9

4.5

1309.13

2797.31

e6/l

1.64

579

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4301

29374

2.16

210.90

6.6

6.0

1.22

mmol/l

1.17

4011

26996

(3037467) Urinalysis macro (dipstick) panel - Urine

5593

42512

2.44

210.27

6.4

4.5

3.30

2.22

0.76

(3026493) Urate [Moles/volume] in Serum or Plasma

2618

14839

2.20

206.94

2.6

323.68

328.88

umol/l

1.90

2279

13063

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4670

33120

2.18

205.16

7.4

6.7

1.22

mmol/l

1.53

4166

28313

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4125

28391

2.07

189.50

2.5

2.1

98.00

97.64

pmol/l

0.18

2070

14131

(3018095) Leukocytes [#/volume] in Urine

3512

23034

2.03

181.64

5.3

3.7

67.63

114.41

e6/l

4.44

2447

15454

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4640

33650

2.08

180.84

5.9

6.7

9.85

11.18

umol/l

20.17

4450

32017

(3013826) Glucose [Moles/volume] in Serum or Plasma

4891

36171

2.11

180.73

5.6

4.5

6.55

6.67

mmol/l

4.02

4726

34206

(3030467) Casts [#/volume] in Urine by Automated count

2812

17080

2.06

179.39

4.0

3.0

0.36

0.48

e6/l

1.82

2040

12112

(3018418) pH of Serum or Plasma

3151

20136

2.01

172.67

4.1

7.40

0.12

2093

14237

(3002582) Erythrocytes [#/volume] in Urine

3104

19734

2.01

172.56

4.2

3.1

25.16

89.22

e6/l

6.04

2352

14565

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3054

19327

2.01

171.80

3.1

2.5

56.44

63.19

u/l

3.94

2862

17749

(36304419) Bacteria [Presence] in Urine

2657

16176

2.02

165.08

3.9

3.0

1430.16

45.98

estimate

0.46

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4278

30690

1.98

164.65

2.9

2.4

79.17

79.54

nmol/l

0.39

3923

27692

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6930

61221

5.13

155.85

22.8

14.4

20.19

24.30

mg/l

26.82

6093

49338

(3024561) Albumin [Mass/volume] in Serum or Plasma

4099

29340

1.93

154.56

4.9

4.7

36.24

35.61

g/l

13.11

3856

27407

(3006504) Eosinophils/Leukocytes in Blood

4043

28887

1.92

152.38

7.4

6.2

2.80

2.81

0.10

3812

26987

(3022096) Basophils/Leukocytes in Blood

4040

28919

1.91

150.73

7.6

6.3

0.71

0.70

1.00

3804

26983

(3019069) Monocytes/Leukocytes in Blood

4042

28975

1.91

149.72

7.6

6.3

8.64

8.77

2.24

3806

27093

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4072

29349

1.90

147.32

3.6

2.9

105.16

118.42

ug/l

3.14

3794

27317

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6123

50990

2.39

146.46

5.8

4.6

14.83

14.84

pmol/l

0.18

5757

46777

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1908

10688

2.07

145.85

3.5

2.7

1.42

1.63

e6/l

0.23

973

5417

(3002030) Lymphocytes/Leukocytes in Blood

4092

29636

1.89

144.76

7.4

6.2

28.34

27.88

2.01

3894

28001

(3018010) Neutrophils/Leukocytes in Blood

4019

28976

1.88

143.81

7.4

6.1

56.89

57.36

1.84

3851

27650

(40768797) Stomach Pathology biopsy report

1618

8593

2.14

141.95

1.3

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3990

28864

1.86

139.49

3.0

2.6

—

estimate

—

(3019150) Specific gravity of Urine by Refractometry

2315

14147

1.94

136.50

5.7

4.0

1.02

1.24

kg/l

0.80

1558

9173

(3032080) INR in Blood by Coagulation assay

3887

28055

1.84

135.13

14.2

13.5

1.20

1.23

inr

3.18

3178

23076

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2300

14137

1.92

132.48

1.4

1.3

1.21

1.76

u/ml

2.32

631

3774

(3048689) Calprotectin [Mass/mass] in Stool

1444

7550

2.14

130.67

2.2

111.19

131.93

ug/g

2.08

1134

5921

(3014051) Protein [Presence] in Urine by Test strip

2736

17854

1.86

130.38

3.7

2.9

0.12

0.04

0.43

474

(3000850) Epithelial cells [#/volume] in Urine

2171

13193

1.93

128.69

3.2

2.6

6.39

7.01

e6/l

1.37

2007

11951

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2800

18480

1.85

128.06

3.2

3.0

1009.46

1330.06

ng/l

3.86

2442

15934

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3279

22844

1.80

124.39

4.5

3.4

78.16

62.17

ng/l

0.19

2297

15599

(3021960) Folate [Moles/volume] in Serum or Plasma

2743

18138

1.83

123.52

1.8

1.6

21.82

20.92

nmol/l

1.55

2360

15234

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2473

15871

1.85

122.44

2.7

2.3

2.65

2.89

mg/l

7.12

2157

13630

(3026008) Bacteria identified in Urine by Culture

3096

21290

1.80

121.95

4.2

3.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6694

59249

3.00

121.08

7.5

5.6

1.81

1.94

mu/l

9.65

6364

54716

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4623

36003

1.80

116.82

3.2

2.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1992

12151

1.89

114.25

1.5

2.26

2.41

g/l

2.47

1137

7273

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1934

11686

1.90

114.23

4.7

3.5

315.64

409.11

ng/l

0.38

1480

9084

(3044889) 12 lead EKG panel

5438

44647

1.91

114.17

4.8

3.9

0.44

1161.55

—

(3033658) Prothrombin time (PT) actual/Normal

2449

16078

1.80

109.76

4.5

3.7

94.47

92.05

5.08

2375

15723

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1666

9717

1.93

108.77

3.7

2.8

3.52

3.63

e6/l

0.14

728

4448

(3007853) Bacteria identified in Skin by Aerobe culture

1250

6600

2.08

108.20

1.9

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

2925

20415

1.73

104.52

2.7

2.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3301

23819

1.72

104.48

3.2

3.7

2.36

mmol/l

0.00

3004

21634

(3042936) Bacteria identified in Isolate by Culture

1418

7940

1.98

103.79

2.2

1.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6968

63890

4.40

103.77

25.3

17.2

139.73

mmol/l

0.03

6919

62522

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6610

58999

2.57

101.29

7.6

6.1

39.32

39.02

mmol/mol

2.36

6273

54775

(3015171) Extractable nuclear Ab [Units/volume] in Serum

585

2288

2.70

100.65

1.3

1.2

0.76

1.49

u/ml

0.83

160

(3023103) Potassium [Moles/volume] in Serum or Plasma

6967

64012

4.30

100.50

25.5

17.4

3.97

3.95

mmol/l

6.71

6912

62527

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1132

5933

2.08

99.21

2.7

2.3

44.14

41.03

u/l

0.10

945

4978

(3008898) HLA-B27 [Presence]

463

1614

3.00

98.75

1.1

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3366

24764

1.68

96.34

5.4

3.8

3.01

0.54

estimate

1.03

688

5416

(3029937) Albumin [Presence] in Urine by Test strip

2641

18250

1.71

95.49

5.6

4.0

0.00

estimate

0.38

806

6279

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2898

20547

1.69

95.08

3.4

3.2

32.14

34.89

u/l

0.68

2748

19368

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1299

7317

1.95

92.31

2.0

1.8

—

(40758558) Short blood count panel - Blood

2770

19520

1.68

92.21

6.2

6.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6691

60636

2.58

88.78

6.3

5.1

5.93

5.88

mmol/l

2.37

6287

55434

(3023420) DNA double strand Ab [Units/volume] in Serum

577

2424

2.50

85.34

1.7

1.8

4.65

7.97

iu/ml

2.62

126

549

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2087

13882

1.71

84.55

2.7

3.0

2.46

mmol/l

1.47

1879

12512

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2260

15365

1.69

84.35

2.6

2.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1213

6875

1.92

83.84

2.1

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1059

5736

1.99

83.61

2.4

2.3

356.18

395.50

nmol/l

8.30

976

5324

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

6643

60260

2.42

83.38

20.8

14.7

79.28

78.89

ml/min/173m2

0.91

6244

55641

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4926

40787

1.67

82.57

3.8

3.1

45.42

45.97

u/l

0.21

4646

38040

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1603

9963

1.78

82.24

2.1

1.8

—

(3021589) Normoblasts [#/volume] in Blood

3667

28282

1.61

81.74

12.2

10.9

0.00

e9/l

0.16

2916

22899

(40761535) Cells panel - Urine sediment

869

4439

2.09

80.45

4.1

3.4

—

0.80

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1553

9703

1.77

77.65

1.6

1.4

—

(3023368) Bacteria identified in Blood by Culture

2338

16331

1.64

77.01

4.5

4.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

859

4454

2.06

76.14

1.3

—

(3000494) Fungus identified in Specimen by Culture

1236

7255

1.85

75.91

1.6

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

345

1183

3.01

75.49

1.6

10750.86

12035.57

e6/l

0.20

221

806

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

899

4778

2.01

74.30

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1215

7199

1.83

72.03

2.5

5.34

8.54

umol/l

13.64

1034

6235

(3022948) Iron [Moles/volume] in Serum or Plasma

1617

10408

1.72

71.98

2.9

2.5

12.82

12.79

umol/l

0.05

1503

9659

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6995

65697

3.83

71.42

16.0

11.8

24.68

24.56

u/l

0.20

6892

63575

(3026782) Osmolality of Urine

1730

11382

1.69

70.81

3.5

2.8

508.01

509.18

mosm/kgh2o

0.08

1529

9899

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7026

66242

4.26

69.91

28.4

19.4

73.59

72.97

umol/l

0.85

6994

65374

(3005322) IgE [Units/volume] in Serum or Plasma

730

3690

2.09

68.97

1.3

138.36

199.68

u/ml

2.50

674

3399

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

768

3998

2.03

66.89

2.5

2.4

21.93

24.09

au/ml

0.22

469

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1607

10507

1.68

66.77

2.9

3.4

0.82

mmol/l

0.02

1493

9864

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

717

3685

2.05

64.59

1.3

40.44

51.50

au/ml

0.59

274

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6776

62930

2.43

64.47

7.1

5.7

2.71

2.78

mmol/l

10.04

6400

58236

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3468

27341

1.52

63.59

2.0

1.9

1.42

1.32

mmol/l

6.67

2961

22709

(3045414) Leukocytes [Presence] in Urine

1021

5965

1.83

62.63

2.3

2.1

0.01

0.02

estimate

0.26

196

1154

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1487

9683

1.68

62.14

2.8

2.4

2.39

2.35

g/l

2.06

1362

8906

(3019309) Folate [Moles/volume] in Red Blood Cells

1588

10524

1.65

61.98

1.8

1.7

1183.33

1174.82

nmol/l

0.14

1230

7861

(3004588) Protein electrophoresis panel - Serum or Plasma

756

4031

1.98

61.28

2.2

2.6

—

(3009508) Creatinine [Moles/volume] in Urine

2829

21522

1.52

60.35

3.4

3.2

6.97

6.77

mmol/l

1.76

2433

18052

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

818

4511

1.92

59.97

1.7

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

903

5143

1.86

59.93

3.6

3.5

86.40

87.09

ng/l

0.07

799

4374

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5807

51612

1.66

59.44

26.2

18.4

13.71

13.66

2.12

5780

50867

(36660697) Celiac disease serology panel - Serum

873

4959

1.87

58.33

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1380

8945

1.67

58.23

2.9

2.5

21.41

21.89

0.70

1273

8286

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6677

61973

2.15

57.93

5.9

5.0

4.71

4.79

mmol/l

9.28

6304

57551

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

606

3060

2.07

57.01

1.1

0.88

2.05

u/ml

1.46

(3022145) Colonoscopy Study observation

1156

7214

1.72

55.99

1.3

—

(3019977) pH of Arterial blood

1123

6969

1.73

55.46

6.8

7.2

7.42

0.90

590

3777

(3012516) Albumin [Mass/volume] in Urine

2700

20603

1.50

55.36

3.4

3.3

39.27

39.21

mg/l

0.00

1671

12014

(3027801) Oxygen [Partial pressure] in Arterial blood

1120

6954

1.72

55.18

6.8

7.2

12.35

12.67

kpa

1.26

1082

6703

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1120

6956

1.72

55.12

6.8

7.2

5.07

5.11

kpa

0.72

1078

6702

(3020630) Protein [Mass/volume] in Serum or Plasma

867

4997

1.84

55.11

2.3

2.9

66.31

66.27

g/l

0.05

786

4560

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

822

4662

1.86

55.01

2.5

2.2

5.67

7.58

ug/l

1.57

712

4047

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6631

61580

2.04

54.39

5.8

4.9

1.53

1.56

mmol/l

8.27

6226

56830

(3014111) Lactate [Moles/volume] in Serum or Plasma

911

5354

1.80

54.26

6.7

6.9

1.28

1.31

mmol/l

0.35

896

5260

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

683

3669

1.95

53.88

1.8

1.7

—

(3003396) Base excess in Arterial blood by calculation

1108

6911

1.71

53.55

6.8

7.2

1.03

1.01

mmol/l

0.05

941

5762

(3007461) Platelets [#/volume] in Blood

7057

67466

4.23

53.42

33.8

22.6

260.53

257.73

e9/l

3.25

6948

65833

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1366

9012

1.64

53.23

2.4

2.0

29.10

29.41

1.22

1328

8779

(3024731) MCV [Entitic mean volume] in Red Blood Cells

7057

67477

4.22

53.18

33.7

22.5

91.62

91.24

11.28

7032

66635

(3035941) MCH [Entitic mass]

7057

67477

4.22

53.18

33.7

22.5

30.34

30.25

4.29

7032

66634

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

7057

67484

4.21

53.02

34.3

22.9

39.93

40.23

1.06

7032

66607

(3026361) Erythrocytes [#/volume] in Blood

7057

67485

4.21

53.00

33.8

22.5

4.40

4.42

e12/l

5.67

6933

65585

(3010813) Leukocytes [#/volume] in Blood

7057

67490

4.20

52.89

33.9

22.6

6.79

6.59

e9/l

11.00

6933

65573

(3000963) Hemoglobin [Mass/volume] in Blood

7057

67498

4.19

52.71

34.1

22.7

132.42

132.95

g/l

3.01

7033

66674

(3000991) Gas panel - Venous blood

878

5155

1.80

52.35

7.8

8.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2719

20960

1.48

52.09

3.9

7.79

7.64

mg/mmol

0.06

1647

12008

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

416

1901

2.26

50.31

1.4

1.3

25.83

55.56

u/ml

1.87

120

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

5732

51425

1.58

49.33

29.1

19.2

330.48

330.87

g/l

3.05

5717

51145

(3016502) Oxygen saturation in Arterial blood

984

6085

1.72

48.71

7.1

7.6

96.03

95.74

0.88

951

5876

(3003327) Ova and parasites identified in Stool by Light microscopy

439

2079

2.18

48.62

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

276

1062

2.66

48.56

1.8

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

939

5740

1.73

48.45

7.4

7.9

120.68

119.44

g/l

1.19

922

5606

(3023520) Reticulocytes [#/volume] in Blood

868

5205

1.76

47.90

2.4

2.6

70.40

69.58

e9/l

0.27

607

3783

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

619

3343

1.93

47.86

3.5

3.6

24.53

24.33

mmol/l

0.97

613

3304

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

487

2421

2.09

47.56

2.2

2.4

7.46

7.47

g/l

0.04

442

2194

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

386

1750

2.27

47.54

1.7

1.6

1.22

1.19

g/l

0.89

369

1655

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

486

2421

2.08

47.19

2.2

2.4

4.20

4.26

g/l

0.85

442

2195

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

485

2417

2.08

47.04

2.2

2.4

3.54

3.70

g/l

1.77

442

2190

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

378

1707

2.28

46.99

1.7

0.24

0.23

g/l

0.30

360

1607

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

307

1266

2.49

46.82

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1872

13628

1.51

46.39

5.1

4.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

432

2076

2.15

46.07

2.1

2.3

9.42

10.43

g/l

5.18

381

1830

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

329

1420

2.38

45.40

1.3

1.2

49.84

45.18

u/ml

0.13

152

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

382

1763

2.23

45.05

1.4

1.3

4.92

4.02

u/ml

0.28

183

(3030981) Hyaline casts [#/volume] in Urine by Automated count

785

4650

1.77

45.05

2.8

2.3

0.29

0.47

e6/l

3.44

734

4437

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

380

1758

2.23

44.55

1.4

1.3

3.18

6.73

u/ml

1.96

288

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

459

2289

2.07

44.39

2.3

2.4

2.90

2.94

g/l

0.43

414

2062

(3027945) Reticulocytes/Erythrocytes in Blood

1058

6826

1.65

44.26

2.5

1.80

1.82

0.27

958

6082

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

429

2105

2.10

43.30

2.3

2.4

0.53

1.07

g/l

3.09

382

1774

(3000570) Elastase.pancreatic [Mass/mass] in Stool

385

1818

2.18

42.89

1.4

298.49

270.24

ug/g

2.10

234

1087

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

375

1755

2.20

42.71

2.3

0.01

0.03

g/l

1.14

346

1553

(3014765) Yersinia sp identified in Stool by Organism specific culture

349

1595

2.25

42.13

1.3

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

937

5941

1.66

41.78

3.7

3.4

5.86

5.79

kpa

1.15

916

5790

(3002032) Base excess in Venous blood by calculation

916

5776

1.67

41.71

3.7

3.4

2.00

1.89

mmol/l

0.42

828

5058

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

345

1578

2.25

41.56

1.3

1.1

—

(3012544) pH of Venous blood

942

5994

1.66

41.40

3.8

3.4

7.38

0.09

468

3414

(42529406) Shigella sp [Presence] in Stool by Culture

347

1599

2.23

41.05

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

340

1568

2.23

40.14

2.3

0.00

g/l

-0.00

321

1462

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6312

58621

1.65

39.71

4.8

4.2

1.35

1.26

mmol/l

19.66

5854

53494

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

101

236

4.33

39.44

1.2

1.5

4.83

6.42

u/l

1.65

197

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

355

1694

2.15

38.48

2.2

2.3

0.00

g/l

-0.00

321

1464

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

322

1481

2.23

38.26

1.4

1.3

2.21

5.71

u/ml

0.96

115

(3017143) Hepatitis C virus Ab [Presence] in Serum

913

5907

1.63

37.30

1.6

1.5

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

799

5014

1.67

36.80

2.5

2.7

67.55

64.93

ml/min/173m2

1.18

360

2060

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

530

2975

1.84

36.09

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

372

1861

2.05

35.58

2.1

2.0

281.48

660.72

ug/l

2.37

352

1751

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

359

1775

2.08

35.45

1.5

4.60

1.74

iu/ml

0.26

307

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

622

3682

1.75

35.43

2.0

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

782

4942

1.65

34.95

3.3

2.8

4.50

4.52

kpa

0.11

766

4808

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

676

4117

1.71

34.75

2.1

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

440

2358

1.92

34.57

1.7

1.6

19.00

18.42

u/ml

0.05

546

(3017732) Neutrophils [#/volume] in Blood

1111

7653

1.53

34.41

3.4

3.2

4.92

4.63

e9/l

0.29

948

6617

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

310

1466

2.17

34.37

1.2

1.1

2.88

3.89

1.35

194

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

388

2001

1.99

34.09

1.2

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2224

17551

1.39

33.35

4.4

3.3

0.51

0.38

estimate

0.12

684

5294

(3004716) Salmonella sp identified in Stool by Organism specific culture

492

2766

1.84

33.28

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

348

1747

2.04

32.96

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

723

4549

1.66

32.78

2.9

3.1

10.03

10.61

g/l

3.52

665

4207

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

599

3585

1.73

32.74

8.4

8.8

24.55

24.39

mmol/l

0.68

582

3518

(3025941) Bacteria identified in Stool by Culture

530

3099

1.77

31.41

1.4

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1014

6983

1.53

31.19

3.6

4.7

239.08

248.94

u/l

0.60

951

6640

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

751

4834

1.62

31.01

2.9

2.8

150.91

197.20

ng/l

3.12

678

4432

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

151

541

2.83

30.56

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1061

7411

1.51

30.46

7.9

6.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1143

8107

1.49

30.44

5.4

5.3

1.05

1.03

mmol/l

1.03

1054

7475

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

543

3252

1.72

29.53

2.5

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

874

5901

1.55

29.31

1.7

1.6

1.48

1.42

1.78

767

5159

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

135

468

2.92

29.03

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

503

2963

1.75

29.01

2.4

2.2

0.07

0.62

estimate

0.77

172

904

(3020961) Endomysium IgA Ab [Titer] in Serum

480

2801

1.76

28.60

1.1

91.00

164.57

titre

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1166

8401

1.46

28.50

1.8

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

442

2531

1.80

28.08

1.9

2.0

40.19

40.10

u/l

0.03

388

2264

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

395

2186

1.85

28.05

1.8

1.7

—

(4034850) Laboratory test

356

1910

1.91

27.83

12.0

9.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

498

2964

1.73

27.66

1.6

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

131

462

2.87

27.33

1.2

1.1

—

(3019060) Gas panel - Arterial blood

555

3419

1.68

27.14

4.0

4.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

213

956

2.27

26.88

1.5

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

688

4484

1.59

26.82

3.0

3.5

4.42

4.45

pmol/l

0.45

616

4015

(3008152) Bicarbonate [Moles/volume] in Arterial blood

572

3583

1.65

26.20

6.3

6.7

24.77

24.68

mmol/l

0.23

553

3425

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1716

13402

1.37

26.16

1.8

1.7

78103653.22

25307353.30

pmol/l

1.81

1434

10997

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

319

1688

1.93

26.00

1.4

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

127

458

2.80

25.45

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

127

458

2.80

25.45

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

125

450

2.81

25.14

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

535

3335

1.65

24.95

8.3

9.7

16.04

15.79

1.42

518

3214

(3013512) EKG study

2643

22117

1.31

24.86

4.0

3.5

0.80

0.74

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

123

444

2.80

24.62

1.2

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

573

3651

1.62

24.47

1.8

2.0

1.36

1.41

g/l

0.23

525

3348

(3018333) Ribosomal P Ab [Presence] in Serum

121

437

2.80

24.20

1.2

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

191

859

2.26

24.02

1.3

1.1

2.17

8.50

u/ml

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

226

1091

2.11

23.81

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

226

1091

2.11

23.81

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1050

7657

1.44

23.69

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

302

1633

1.89

23.06

2.9

3.1

1.26

2.34

index

3.68

151

803

(44816559) Phosphatidylethanol [Mass/volume] in Blood

350

1982

1.81

23.06

1.6

1.5

0.32

0.30

mg/l

0.21

151

867

(3004119) Hemoglobin [Mass/volume] in Venous blood

567

3661

1.60

22.89

2.9

129.25

127.43

g/l

1.21

551

3560

(3006571) Granulocytes/Leukocytes in Synovial fluid

132

516

2.59

22.64

1.6

1.5

53.10

54.32

0.11

314

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

441

2686

1.68

22.45

2.1

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

159

682

2.36

22.36

1.5

1.2

—

(4024509) Urine culture

472

2943

1.65

21.95

2.3

1.9

—

(3024928) Oxygen saturation in Venous blood

270

1431

1.92

21.92

2.3

2.7

58.11

60.97

1.21

259

1393

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

276

3.18

21.91

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

292

1593

1.87

21.70

2.0

2.2

11.25

11.52

mg/l

0.27

268

1493

(4094501) Cardiovascular stress test using bicycle ergometer

291

1610

1.84

20.70

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

350

2.85

20.66

1.3

—

(3019230) Fractional oxyhemoglobin in Venous blood

232

1201

1.96

20.21

2.0

2.5

56.22

61.31

2.81

232

1195

(3039162) Centromere protein B Ab [Units/volume] in Serum

174

815

2.16

19.87

1.4

1.3

59.32

70.78

u/ml

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

349

2068

1.72

19.67

2.8

3.6

36.17

48.64

mg/l

3.78

303

1713

(3004616) Nuclear Ab [Presence] in Serum

160

728

2.23

19.64

1.5

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

345

2.81

19.46

1.3

—

(40768443) Skin Pathology biopsy report

463

2964

1.60

19.33

1.3

1.2

—

(1002224) Polysomnography panel

412

2564

1.64

19.30

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

347

2068

1.71

19.15

2.8

3.6

30.14

51.82

mg/l

2.76

301

1719

(3020779) Urea [Moles/volume] in Serum or Plasma

724

5115

1.46

19.11

6.9

6.8

9.22

9.69

mmol/l

1.12

686

4883

(3010144) Erythrocytes [#/volume] in Synovial fluid

105

406

2.61

18.49

1.3

1.4

205339.29

156366.78

e6/l

0.20

261

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

663

4633

1.48

18.49

1.3

1.2

131.76

145.21

u/ml

0.37

256

1826

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

191

959

2.02

18.18

1.1

19.75

12.20

au/ml

0.73

210

(3018405) Lactate [Moles/volume] in Arterial blood

314

1848

1.73

18.14

3.9

3.7

1.32

1.35

mmol/l

0.15

308

1815

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

182

3.43

17.75

1.1

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1585

12838

1.30

17.71

1.5

—

(3022621) pH of Urine by Test strip

700

4986

1.45

17.65

3.1

2.7

6.07

6.08

0.08

454

3342

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

131

577

2.29

17.42

1.4

1.5

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

102

401

2.57

17.40

1.5

32.36

33.74

0.12

228

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

115

479

2.42

17.36

1.5

1.7

338.61

391.20

mu/l

0.85

376

(3036489) Thrombin time

351

2160

1.66

17.19

2.4

1.8

20.33

21.08

2.80

315

1928

(3021879) Hepatitis B virus core Ab [Presence] in Serum

582

4022

1.49

17.13

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

258

2.97

17.13

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

179

900

2.01

17.00

1.4

31.07

36.70

u/l

1.39

141

729

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

6.24

16.72

1.0

0.02

0.03

u/ml

0.34

(3049717) Cytology report of Urine Cyto stain

305

1826

1.70

16.58

2.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

308

1849

1.70

16.58

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

306

1836

1.70

16.50

2.7

3.4

2.14

4.82

ratio

1.68

177

1026

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

160

785

2.06

16.27

1.3

1.2

2.93

3.39

u/ml

0.32

347

(3025159) Blasts/Leukocytes in Blood

743

5433

1.41

16.16

4.9

4.4

0.08

0.47

2.25

186

1369

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

158

780

2.05

15.81

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

365

2322

1.60

15.65

1.6

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

125

566

2.23

15.61

1.6

1.4

2.80

2.88

g/l

0.19

402

(3027135) IgG subclass 1 [Mass/volume] in Serum

125

566

2.23

15.61

1.6

1.4

6.12

6.99

g/l

2.41

401

(3024139) IgG subclass 3 [Mass/volume] in Serum

125

566

2.23

15.61

1.6

1.4

0.42

0.41

g/l

0.10

399

(3024980) IgG subclass 4 [Mass/volume] in Serum

182

949

1.94

15.61

1.6

1.5

0.63

0.77

g/l

1.38

151

726

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

269

1587

1.72

15.45

1.6

1.5

14.11

20.73

iu/ml

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

275

1634

1.71

15.39

3.3

2.2

196.40

196.04

0.02

257

1559

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

131

612

2.16

15.16

1.3

1.2

21.20

42.88

u/ml

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

125

574

2.20

15.10

1.2

1.1

99.93

95.15

1.19

115

543

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

410

2708

1.55

14.95

1.8

1.7

1.58

1.59

g/l

0.05

361

2328

(3021387) Prolactin [Units/volume] in Serum or Plasma

257

1516

1.72

14.78

1.8

341.13

315.86

mu/l

0.30

230

1380

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

159

813

1.98

14.46

1.3

1.2

1.63

3.49

u/ml

3.06

296

(3017315) Amylase [Enzymatic activity/volume] in Urine

273

2.73

14.39

1.6

1.2

493.34

264.53

u/l

0.30

254

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

831

6305

1.36

14.38

2.2

0.22

0.21

g/l

7.00

770

5916

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

196

1077

1.84

14.35

1.1

0.90

1.98

u/ml

2.02

109

556

(3017181) Myelocytes/Leukocytes in Blood

751

5609

1.38

14.34

4.6

4.2

0.91

0.99

0.27

203

1674

(4062490) Immunoglobulin typing, IgG

120

554

2.19

14.33

1.6

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

103

446

2.33

14.33

1.4

1.3

0.46

1.40

u/ml

1.74

263

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

511

3569

1.46

14.23

4.0

3.5

5.16

5.17

kpa

0.06

486

3407

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

268

1617

1.68

14.20

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

149

3.37

14.05

1.1

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

222

1276

1.76

14.01

1.2

3.80

3.72

mmol/l

0.49

207

1214

(3021440) Promyelocytes/Leukocytes in Blood

721

5371

1.38

13.98

4.7

4.2

0.11

0.13

0.22

171

1445

(3024891) Influenza virus A+B Ag [Presence] in Specimen

243

1434

1.72

13.97

1.2

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

440

2995

1.50

13.94

4.2

3.6

50.71

47.30

2.23

435

2950

(3003181) Sodium [Moles/volume] in Urine

219

1256

1.77

13.93

1.4

61.34

61.73

mmol/l

0.05

184

994

(4268621) Lupus anticoagulant assay

120

562

2.15

13.84

2.5

2.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

165

877

1.90

13.42

1.7

1.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

174

942

1.87

13.38

1.2

1.3

5.37

3.79

nmol/l

0.12

168

896

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

324

2081

1.58

13.38

2.0

2.1

28.71

7.87

iu/l

0.37

123

869

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

137

684

2.02

13.36

1.3

1.2

—

34.88

—

(4195642) Thrombophilia screening test

148

761

1.96

13.29

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

177

968

1.85

13.19

1.2

1.3

0.28

0.25

nmol/l

0.08

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

316

2.52

13.11

1.1

2.80

13.25

nmol/l

1.27

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

146

751

1.96

13.10

1.2

1.1

129.85

118.61

3.38

133

677

(3002179) Metamyelocytes/Leukocytes in Blood

706

5311

1.37

12.85

4.4

4.1

0.69

0.78

0.44

198

1569

(44813793) Dust mix specific IgE antibody measurement

419

2.28

12.72

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

241

1458

1.68

12.67

1.3

460.75

539.72

mg/l

2.61

235

1392

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

304

1952

1.58

12.58

2.6

2.7

—

(3034891) Synovial lining cells/cells in Synovial fluid

219

2.80

12.54

1.6

1.4

4.29

2.72

—

(3009343) pH of Capillary blood

487

3457

1.44

12.45

4.0

3.5

7.42

0.38

396

2866

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

211

1239

1.72

12.40

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

376

2.33

12.22

1.6

2.3

17.57

17.54

nmol/l

0.01

355

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

146

772

1.91

12.11

1.1

3.15

2.97

0.07

129

(3007566) Smooth muscle Ab [Titer] in Serum

277

1767

1.59

11.81

1.2

114.40

184.84

titre

0.89

153

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

212

1270

1.69

11.60

1.3

1.4

12.06

42.11

e6/l

1.75

160

928

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

153

834

1.85

11.57

1.2

1.3

0.17

0.21

nmol/l

1.15

110

650

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

471

6472

0.71

11.53

2.0

3.34

3.32

ratio

0.19

358

4997

(3034770) Mitochondria Ab [Titer] in Serum

277

1779

1.58

11.48

1.2

658.00

771.13

titre

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

426

2996

1.45

11.46

3.7

3.4

1.91

2.14

mmol/l

0.72

321

2255

(3028707) Methadone [Presence] in Urine by Screen method

115

571

2.03

11.45

2.5

2.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

165

924

1.80

11.45

2.8

2.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

801

6249

1.32

11.37

4.9

4.4

22.23

22.01

0.16

405

3130

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

114

567

2.03

11.30

3.7

3.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

442

3139

1.43

11.28

1.4

1.3

29.47

35.69

iu/l

3.78

370

2706

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

110

3.47

11.23

1.0

—

(3024263) Appearance of Synovial fluid

216

2.70

11.16

1.7

1.6

—

(3047181) Lactate [Moles/volume] in Blood

266

1704

1.58

11.16

4.2

5.9

1.18

1.32

mmol/l

2.38

238

1514

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

212

1288

1.67

11.02

1.3

1.4

802.73

1035.92

e6/l

0.24

169

1013

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

153

852

1.81

10.83

1.3

290.38

315.41

pmol/l

0.46

140

745

(3011985) Renin [Units/volume] in Plasma

162

918

1.78

10.83

1.5

77.47

50.05

mu/l

0.87

146

829

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

186

2.81

10.81

1.3

1.2

0.29

0.30

g/l

0.41

142

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

262

1687

1.57

10.76

1.4

1.3

180.18

231.11

miu/ml

1.72

117

803

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

270

1754

1.56

10.67

2.6

2.0

100.15

93.33

5.51

257

1687

(3023419) Bacteria identified in Sputum by Culture

138

749

1.86

10.62

2.5

2.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

135

729

1.87

10.56

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

376

2.22

10.50

1.2

1.1

34.91

41.60

mg/l

0.59

313

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

441

2.12

10.50

1.1

7.64

8.35

iu/ml

0.10

111

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

108

542

2.01

10.48

1.1

—

4.72

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

965

7802

1.27

10.39

6.0

5.5

1.95

3.61

ug/l

2.33

884

6965

(3003888) Timothy IgE Ab [Units/volume] in Serum

162

930

1.76

10.37

1.1

3.06

3.31

u/ml

0.10

461

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

379

2658

1.45

10.36

4.2

4.9

1.67

1.56

1.21

361

2518

(3047007) Chlamydophila sp Ab [Presence] in Serum

143

798

1.81

10.09

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

364

2.21

10.03

1.1

226.14

253.16

mg/l

0.79

314

(3015235) Bicarbonate [Moles/volume] in Capillary blood

290

1942

1.51

10.00

3.0

2.7

25.18

25.13

mmol/l

0.07

284

1900

(3010726) Horse dander IgE Ab [Units/volume] in Serum

151

859

1.77

9.99

1.1

0.53

1.41

u/ml

2.60

407

(3024522) Salmonella sp identified in Specimen by Organism specific culture

132

722

1.84

9.94

1.4

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

225

2.55

9.82

1.3

1.4

74.65

330.17

nmol/24h

1.11

225

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

140

786

1.80

9.70

1.2

1.3

—

nmol/l

—

(3002256) Pathology report gross observation

1106

9167

1.24

9.57

1.3

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

278

2.35

9.45

1.2

0.52

0.61

ratio

1.71

154

(3016244) Insulin [Units/volume] in Serum or Plasma

291

2.31

9.41

2.9

3.4

28.98

23.06

mu/l

0.53

280

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

230

2.49

9.40

2.2

1.5

176.35

149.60

umol/l

0.19

116

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

162

2.79

9.30

1.8

2.0

9.80

10.07

mg/l

0.10

130

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

106

553

1.93

9.26

1.2

114.75

117.50

pmol/l

0.20

106

553

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

471

2.01

9.22

1.5

1.4

30.41

19.54

u/ml

1.11

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

301

2.27

9.15

1.6

1.7

2.50

5.93

nmol/l

1.22

245

(3025468) Yersinia sp identified in Specimen by Organism specific culture

124

684

1.83

9.13

1.4

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

102

1879

0.54

9.09

1.0

1.1

0.54

0.60

ratio

0.88

295

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

124

685

1.82

9.09

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

124

686

1.82

9.05

1.4

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

468

2.00

9.02

3.7

2.4

22.63

26.64

mg/l

0.40

320

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

128

716

1.80

9.01

1.4

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

133

753

1.78

8.99

2.4

2.0

17.58

24.60

mg/l

1.30

276

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

230

1506

1.54

8.84

1.1

5.55

9.65

eliau/ml

0.75

175

(3023430) Cat dander IgE Ab [Units/volume] in Serum

129

730

1.78

8.75

1.1

1.56

3.71

u/ml

2.22

296

(3038026) Centromere Ab [Units/volume] in Serum

460

1.99

8.73

1.3

1.2

109.27

65.65

u/ml

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

341

2425

1.43

8.69

4.3

5.1

0.87

0.88

0.22

324

2289

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

165

1003

1.66

8.65

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

100

524

1.92

8.65

1.4

1.2

97.33

79.27

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

152

905

1.69

8.62

1.1

0.36

0.96

u/ml

2.06

377

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

129

735

1.77

8.56

1.2

52.48

59.08

u/l

0.63

113

649

(3018572) Chloride [Moles/volume] in Blood

185

1165

1.60

8.44

4.8

7.1

104.42

105.17

mmol/l

1.23

170

1045

(3039000) Anion gap in Blood by calculation

185

1165

1.60

8.44

4.8

7.1

10.99

11.17

mmol/l

0.33

170

1045

(3038177) Helicobacter pylori Ab [Presence] in Serum

162

989

1.65

8.37

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

160

974

1.66

8.36

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

167

2.64

8.26

1.2

1.1

97.83

91.14

0.67

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

104

561

1.87

8.26

1.3

1.62

1.47

nmol/l

0.66

505

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

117

655

1.80

8.25

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

415

2.01

8.23

1.8

1.7

117.23

101.62

ng/l

0.42

415

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

163

2.65

8.10

1.3

1.1

98.87

90.75

0.62

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

353

4801

0.72

8.09

1.7

3.52

mmol/l

0.03

245

3349

(3032057) Clostridioides difficile [Presence] in Stool

103

3.12

8.08

2.0

1.9

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

237

2.33

7.92

1.1

3.33

3.92

iu/ml

—

(21494755) Public health laboratory ask at order entry panel

386

5159

0.73

7.91

1.3

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

137

2.78

7.88

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

261

1803

1.46

7.80

4.2

3.9

24.99

25.09

mmol/l

0.26

231

1651

(1761868) Lipid panel - Serum or Plasma

2196

24328

0.86

7.75

3.3

3.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

432

1.96

7.72

1.3

1.2

20.19

23.21

u/l

0.34

365

(37208534) Antinuclear antibody arbitrary concentration in serum

191

2.47

7.71

1.1

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

294

2090

1.42

7.55

2.5

2.1

12.01

12.18

nmol/l

0.13

263

1859

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

268

1874

1.45

7.53

3.0

2.8

0.35

0.37

iu/ml

0.44

150

1044

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

436

1.94

7.53

1.3

1.2

81.10

87.18

u/l

0.34

379

(3025018) Bordetella pertussis Ab [Titer] in Serum

417

1.95

7.44

1.2

—

(3008295) Osmolality of Serum or Plasma

117

677

1.74

7.42

1.3

1.4

273.81

275.92

mosm/kgh2o

0.48

511

(3037756) Immunofixation for Serum or Plasma

195

1283

1.53

7.40

1.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

404

1.97

7.40

1.4

1.2

26.00

71.03

titre

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

208

1388

1.51

7.40

2.1

1.9

6976.62

4791.44

u/l

0.29

563

(3014133) Dog dander IgE Ab [Units/volume] in Serum

131

784

1.68

7.35

1.1

3.06

2.93

u/ml

0.03

366

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

337

2.06

7.34

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

171

1095

1.58

7.32

1.3

13.58

15.34

u/l

0.79

131

881

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

207

1383

1.51

7.32

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

193

1271

1.53

7.30

1.7

1.9

4.77

5.07

mmol/24h

0.64

174

1124

(3016038) Potassium [Moles/volume] in Urine

435

1.92

7.25

1.3

1.2

33.71

34.29

mmol/l

0.08

376

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

3.15

7.24

1.2

45.27

41.06

0.22

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

197

2.39

7.23

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

173

2.49

7.22

1.3

1.1

115.47

106.72

0.83

158

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

114

661

1.74

7.19

1.1

1.0

0.06

0.32

u/ml

0.95

205

(1001926) Buprenorphine [Presence] in Urine by Screen method

166

1062

1.58

7.15

2.2

1.7

—

(3033099) Centromere Ab [Titer] in Serum

139

2.67

7.13

1.2

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

123

2010

0.61

7.12

1.1

1.2

1.59

1.60

g/l

0.08

123

2010

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

246

1712

1.45

7.11

2.9

2.3

3.70

3.60

g/l

0.49

234

1641

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

205

2.35

7.10

1.5

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

316

2301

1.39

7.09

2.0

1.9

1.05

2.18

ug/l

3.30

273

2039

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

117

687

1.71

7.06

6.7

6.1

12.64

12.31

mg/l

0.28

103

639

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

218

2.30

7.06

1.1

33.36

301.74

ng/l

2.20

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

771

6348

1.24

7.01

3.5

3.3

—

(3002619) Bacteria identified in Specimen by Culture

129

2.72

7.00

1.5

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

469

1.87

6.99

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

462

1.87

6.99

1.1

—

(3000330) Specific gravity of Urine by Test strip

418

3190

1.33

6.95

4.1

3.4

1.02

ratio

0.41

375

2888

(3006653) Thiamine [Moles/volume] in Blood

271

2.15

6.94

1.3

135.16

134.18

nmol/l

0.07

271

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

414

1.92

6.92

1.4

1.2

310.00

409.63

titre

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

500

1.83

6.89

1.4

1.8

6.48

8.75

umol/l

0.68

360

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

215

2.29

6.83

1.6

0.41

0.39

ug/l

0.18

142

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

267

2.14

6.79

1.0

1.1

1.33

1.18

u/l

0.28

117

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

462

1.85

6.68

2.1

1.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

359

2699

1.35

6.62

3.7

3.0

25.51

25.26

mmol/l

0.75

344

2628

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

200

2.31

6.56

2.2

2.3

48.94

50.56

umol/l

0.14

174

(3009466) Valproate [Moles/volume] in Serum or Plasma

126

771

1.65

6.55

5.1

5.7

348.48

372.30

umol/l

1.06

115

678

(3044927) Protein electrophoresis panel - Urine

546

1.77

6.51

1.3

1.2

—

(4198724) Urine methamphetamine measurement

140

2.58

6.51

1.3

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

254

2.13

6.39

1.3

1.2

162.70

148.17

mmol/24h

0.43

254

(3003694) ABO and Rh group [Type] in Blood

1921

17279

1.15

6.36

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

217

1513

1.45

6.26

1.3

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

158

1035

1.54

6.19

1.2

126.25

373.99

titre

2.53

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.66

6.19

1.0

1.1

1.50

1.65

umol/24h

0.42

(44806118) Parainfluenza type 4 nucleic acid detection

119

729

1.64

6.18

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

119

729

1.64

6.18

1.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

119

729

1.64

6.18

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

119

729

1.64

6.18

1.6

1.4

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

6.26

6.15

1.1

1.0

0.24

0.21

u/ml

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

193

1326

1.47

6.03

1.6

1.4

—

(3019225) pH of Specimen

749

6253

1.22

5.97

5.2

4.1

7.36

0.33

527

4323

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

366

1.89

5.89

1.1

1.2

91.00

84.75

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

101

2.78

5.87

1.4

1.1

105.43

80.74

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

5.78

5.82

1.1

1.0

0.28

0.22

u/ml

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

146

954

1.54

5.81

1.4

166.93

151.66

au/ml

0.83

258

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

102

2.75

5.77

1.5

1.1

115.57

78.39

—

(3006270) Folate [Moles/volume] in Blood

464

1.78

5.71

1.3

1.1

363.13

357.97

nmol/l

0.08

394

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

246

2.08

5.70

1.6

1.2

2.97

3.86

umol/l

1.52

219

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

132

2.51

5.68

3.2

3.0

7.58

8.23

mg/l

0.24

108

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

2.47

5.68

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

207

1461

1.43

5.63

2.4

2.2

130.76

128.16

g/l

1.00

159

1095

(3019832) Treponema pallidum Ab [Presence] in Serum

468

3734

1.27

5.62

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.88

5.61

1.9

2.0

13.78

17.44

umol/l

1.14

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

467

1.76

5.60

1.3

9.18

8.76

mmol/l

0.36

442

(3028626) Oxygen [Partial pressure] in Capillary blood

195

1367

1.44

5.52

3.1

2.9

8.32

8.08

kpa

1.14

190

1330

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

114

714

1.61

5.47

1.1

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

153

2.36

5.46

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.34

5.43

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

156

1052

1.49

5.39

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

293

1.95

5.37

1.3

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

186

2.21

5.36

1.5

1.9

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

124

2.51

5.35

1.1

0.57

0.65

umol/24h

0.61

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

621

5146

1.23

5.33

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

226

2.09

5.32

1.6

1.7

4384.00

3277.42

titre

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

338

1.87

5.24

1.2

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

157

2.30

5.17

1.0

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

214

1546

1.40

5.14

1.7

1.6

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

147

992

1.49

5.09

2.2

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

147

992

1.49

5.09

1.2

24.55

40.21

u/l

1.61

136

851

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.17

5.03

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

116

2.51

5.02

2.6

2.2

23.97

161.42

au/ml

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

101

629

1.61

5.00

1.5

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

566

4678

1.23

4.99

3.3

3.2

0.62

0.82

ug/l

8.16

398

3102

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

154

2.28

4.94

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

160

1107

1.46

4.90

1.6

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

145

984

1.48

4.90

1.3

1.2

293.29

271.03

u/ml

0.23

605

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

114

735

1.56

4.88

1.1

—

0.50

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

164

1141

1.45

4.88

1.5

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

218

1596

1.38

4.86

1.7

1.6

—

(3016879) Cocaine [Presence] in Urine

180

1278

1.42

4.80

2.2

1.7

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

230

2.01

4.73

1.1

1.3

8.70

11.26

mm/h

1.35

230

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

205

1493

1.38

4.73

1.7

1.6

—

(3023410) Appearance of Cerebral spinal fluid

571

1.62

4.64

1.3

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.97

4.54

1.1

1.0

0.02

0.05

u/ml

0.89

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

590

1.60

4.54

1.6

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

545

1.62

4.49

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

263

1.91

4.47

1.4

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

515

1.64

4.47

2.0

1.8

162.05

188.83

pmol/l

1.37

494

(3000764) Benzodiazepines [Presence] in Urine

192

1398

1.38

4.46

2.1

1.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.53

4.45

1.2

1.3

118.63

75.42

mg/l

0.13

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

264

1.90

4.42

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

193

1410

1.38

4.39

2.1

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

109

714

1.53

4.39

1.9

1.7

45.98

44.63

nmol/l

0.20

103

694

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

544

1.61

4.29

3.3

2.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

120

2.34

4.23

1.3

0.20

0.43

mmol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

114

2.37

4.22

1.1

30.24

34.67

iu/ml

0.15

114

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

102

2.46

4.20

1.3

1.6

—

(3027008) Opiates [Presence] in Urine

190

1403

1.36

4.08

2.1

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

591

1.56

4.07

1.7

2.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

369

1.71

4.01

1.1

14.84

17.02

u/ml

0.26

143

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

293

2309

1.28

3.98

2.1

1.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

163

1180

1.39

3.96

2.4

2.3

140.98

61.32

ug/min

1.07

682

(3000034) Microalbumin [Mass/volume] in Urine

501

1.60

3.95

3.1

2.9

58.43

17.93

mg/l

0.71

352

(3012494) Peanut IgE Ab [Units/volume] in Serum

131

2.22

3.91

1.0

1.1

1.34

1.38

u/ml

0.02

(3014271) Vancomycin [Susceptibility]

255

1.85

3.87

3.8

2.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

528

1.58

3.85

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

427

1.65

3.85

1.6

1.5

4.40

5.90

u/l

0.72

357

(3036670) Protein [Mass/volume] in Synovial fluid

132

2.20

3.85

1.6

1.3

34.43

38.67

g/l

0.93

(3020191) Ethanol [Moles/volume] in Serum or Plasma

345

1.72

3.80

1.6

1.4

1.20

1.13

promille

0.15

258

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.60

3.80

1.0

—

(3027944) Amphetamines [Presence] in Urine

186

1390

1.35

3.73

2.1

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

121

2.24

3.72

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

586

1.53

3.58

1.3

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

143

2.10

3.58

1.1

—

(3034426) Prothrombin time (PT)

150

2.07

3.56

1.3

1.2

30.16

27.86

0.70

150

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

165

1222

1.36

3.53

5.5

5.1

395.96

1934.39

iu/ml

0.61

171

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

134

959

1.40

3.53

2.6

2.5

250.33

2309.21

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

485

1.57

3.52

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

346

1.68

3.50

1.0

1.1

0.33

2.54

u/ml

1.20

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

5.30

3.50

1.0

1.1

0.03

0.04

u/ml

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

10.01

3.49

1.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

10.01

3.49

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

10.01

3.49

1.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

2.37

3.47

1.2

1.4

121.71

117.47

ug/l

0.06

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

266

2119

1.27

3.37

2.1

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

101

1448

0.69

3.35

1.4

1.6

946.87

1033.50

mu/l

0.59

1186

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

163

1.97

3.23

3.9

3.1

4.85

5.09

kpa

0.76

163

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

163

1.97

3.23

3.9

3.1

10.04

9.98

kpa

0.05

163

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

170

1.95

3.22

1.7

8.23

8.93

ug/l

0.64

170

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

316

2582

1.23

3.21

3.0

3.6

92.63

1448.26

u/ml

2.94

263

2211

(3017354) Segmented neutrophils/Leukocytes in Blood

610

1.48

3.20

3.8

3.7

59.13

57.73

0.27

520

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

5.34

3.19

1.0

0.00

0.26

u/ml

—

(3042517) Benzodiazepines panel - Urine

3.80

3.18

1.1

2.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

164

1.96

3.18

1.0

4.36

11.12

u/ml

1.58

112

(4133840) Spirometry

104

2.22

3.15

1.3

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

856

0.62

3.14

1.4

1.5

58.85

59.30

ug/l

0.02

710

(3013005) Retinol [Moles/volume] in Serum or Plasma

282

1.71

3.11

1.6

1.7

2.00

1.96

umol/l

0.13

260

(3008757) Leukocyte morphology finding [Identifier] in Blood

566

1.49

3.08

3.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

108

767

1.41

3.02

1.1

2.11

3.04

eliau/ml

0.74

356

(4035726) Immunohistochemistry procedure

586

6710

0.86

2.99

1.3

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

100

2.20

2.98

1.0

0.36

3.65

u/ml

0.66

(3014148) Varicella zoster virus Ab [Titer] in Serum

100

703

1.43

2.97

1.1

—

(44786800) Granulocytes/Leukocytes in Body fluid

0.00

2.95

0.0

1.2

—

21.72

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

396

1.57

2.92

1.6

1.8

—

(1616796) Gas panel - Central venous blood

164

1259

1.31

2.83

4.0

3.7

—

(3025130) Human papilloma virus identified in Specimen

157

1198

1.32

2.83

1.6

1.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

208

1.78

2.81

3.2

3.1

24.09

27.67

umol/l

1.15

153

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

122

897

1.37

2.81

1.7

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

2.77

2.81

1.8

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

170

1313

1.30

2.81

1.5

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

679

1.42

2.78

2.3

2.5

1.01

1.06

g/24h

0.07

376

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.55

2.78

1.4

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

323

1.61

2.76

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

378

1.57

2.76

1.3

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

316

1.62

2.74

1.2

1.04

1.07

ratio

1.14

249

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

293

1.64

2.74

1.2

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

293

1.64

2.74

1.2

1.6

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

3.24

2.72

1.2

1.3

56.00

44.50

—

(3051611) Lipemic interference index of Serum or Plasma

649

1.42

2.71

3.1

3.2

16.48

12.89

index

1.29

348

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

270

2218

1.23

2.67

1.8

1.7

4.72

4.50

mg/l

0.11

240

1619

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

288

1.64

2.65

1.1

1988.40

1426.59

miu/ml

2.19

288

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.79

2.64

1.0

0.00

0.22

u/ml

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

235

1.71

2.64

1.0

1.1

3.41

7.21

u/ml

0.74

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

612

5397

1.15

2.63

3.2

3.7

1.24

1.23

mmol/l

1.04

532

4581

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

258

1.67

2.63

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

258

1.67

2.63

1.3

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

391

1.54

2.62

1.3

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.39

2.62

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.34

2.60

1.3

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.67

2.59

1.3

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.60

2.57

1.0

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

107

2.06

2.56

1.1

1.4

1.18

mmol/l

0.03

107

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

372

0.48

2.56

1.2

1.3

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

2.36

2.55

1.2

1.3

42.43

54.76

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

248

1.66

2.45

2.8

2.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

790

0.66

2.43

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

120

905

1.33

2.40

1.3

1.4

0.29

0.35

nmol/l

0.57

666

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.35

2.38

1.1

1.0

0.03

1.74

u/ml

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.50

2.35

1.0

0.40

1.03

u/ml

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

132

1.90

2.35

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

132

1.90

2.35

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

132

1.90

2.35

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

132

1.90

2.35

1.1

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

275

1.60

2.33

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

316

1.55

2.29

2.2

1.5

72.41

80.24

umol/l

1.82

316

(3037121) Protein [Mass/volume] in Urine

240

1985

1.22

2.27

3.2

3.3

724.85

380.42

mg/l

0.49

102

814

(3005011) Chlamydia sp Ab [Titer] in Serum

2.22

2.27

1.9

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

472

1.44

2.24

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

799

0.67

2.24

1.4

1.02

0.95

ratio

0.20

481

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

799

0.67

2.24

1.4

1.13

1.21

ratio

0.18

483

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

798

0.67

2.23

1.4

0.93

1.14

ratio

1.29

480

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

263

1.60

2.22

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.05

2.21

1.5

1.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.86

2.20

1.2

1.0

29.80

63.82

u/l

—

(3005033) Fetal Nuchal fold Thickness US

662

0.65

2.17

1.3

1.4

1.26

1.27

0.02

472

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.62

2.14

1.8

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

680

1.36

2.14

5.1

6.6

7.03

7.49

mmol/l

0.67

575

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

629

1.37

2.13

3.8

5.6

199.30

120.25

u/ml

0.24

203

(3043238) Trisomy 21 risk [Likelihood] in Fetus

695

0.66

2.13

1.4

1.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

5.00

2.07

3.2

1.5

1.94

2.05

mmol/24h

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.71

2.06

1.0

0.06

0.03

u/ml

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

333

1.51

2.05

1.0

0.32

0.71

u/ml

1.03

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

285

1.55

2.05

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.11

2.02

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.11

2.02

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.50

2.01

1.4

1.2

3.90

6.84

mmol/l

—

(3019174) dRVVT (LA screen)

2.50

2.01

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

671

0.67

1.98

1.3

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

119

1.85

1.96

1.2

2.0

—

(40768446) Kidney Pathology biopsy report

195

1.64

1.92

1.9

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

574

5163

1.12

1.88

2.9

4.1

81.83

68.24

u/ml

0.17

549

4984

(3026250) Tacrolimus [Mass/volume] in Blood

212

1.61

1.87

46.7

35.2

7.53

7.14

ug/l

0.51

185

(3025577) Chromium [Mass/volume] in Blood

324

1.48

1.87

2.3

2.92

2.67

ug/l

0.20

275

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

499

1.39

1.87

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

499

1.39

1.87

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

499

1.39

1.87

1.4

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.65

1.86

1.0

1.1

6.22

16.29

u/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

168

1373

1.23

1.85

3.8

3.3

0.75

0.82

nmol/l

0.93

143

1121

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

132

1050

1.26

1.85

1.8

1.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

277

1.52

1.83

1.5

1.6

31.30

29.68

umol/l

0.43

257

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

198

0.45

1.83

1.8

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

141

1134

1.25

1.80

1.8

1.6

0.87

0.83

nmol/l

0.30

119

963

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

452

1.40

1.80

1.3

1.4

1.92

2.13

mmol/l

1.90

417

(3017704) Immunofixation for Urine

303

1.49

1.79

1.5

2.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

500

0.64

1.79

1.4

1.5

57.78

62.58

ug/l

0.22

500

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

107

834

1.29

1.77

1.0

1.1

1.46

1.52

g/l

1.24

758

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

161

1.68

1.77

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

296

1.49

1.76

1.5

1.24

1.27

nmol/l

0.06

213

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.67

1.72

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.92

1.72

1.0

0.01

0.28

u/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

708

0.70

1.71

1.5

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

140

1.72

1.71

1.9

1.4

—

(4281824) Cell count and differential, peritoneal fluid

1163

0.77

1.69

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.95

1.69

1.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

382

1.42

1.69

1.1

65.42

79.59

u/l

1.57

338

(3003740) Influenza virus B Ag [Presence] in Specimen

120

959

1.26

1.65

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.98

1.64

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

310

1.45

1.63

1.3

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

294

1.47

1.61

1.1

—

(3010421) pH of Blood

224

1911

1.18

1.61

3.1

3.5

7.41

0.16

224

1888

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

238

1.52

1.59

2.1

2.0

181.67

127.58

ug/min

—

(3002523) Influenza virus A Ag [Presence] in Specimen

119

958

1.25

1.55

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

381

1.39

1.54

1.2

1.1

16.55

21.49

u/l

0.50

336

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

192

1.56

1.53

2.8

0.62

0.61

mmol/l

0.68

192

(4211845) Urine protein measurement

306

1.44

1.53

4.4

3.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

365

1.40

1.52

1.8

2.7

224.48

223.18

e6/l

0.02

317

(3010375) cycloSPORINE [Mass/volume] in Blood

225

1.51

30.7

29.5

112.25

111.59

ug/l

0.02

191

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.86

1.50

1.8

1.4

435.50

284.67

umol/24h

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

342

3031

1.13

1.48

1.5

1.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.12

1.44

3.0

2.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.13

1.44

1.0

1.1

23.86

35.85

umol/24h

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

245

1.47

1.41

2.4

2.2

39.98

40.07

g/l

0.03

245

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

535

1.31

1.40

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.89

1.38

1.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

120

982

1.23

1.38

3.7

3.5

0.79

1.73

6.65

107

883

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

174

1.55

1.36

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.94

1.36

1.2

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.94

1.36

1.0

—

(40768795) Lymph node Pathology biopsy report

790

0.76

1.35

1.2

—

(3006462) Nitrate [Presence] in Urine

281

1.43

1.35

4.7

3.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

273

1.43

1.34

5.9

4.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.14

1.33

1.3

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.13

1.33

1.4

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

128

1.64

1.33

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

384

1.36

1.32

2.3

2.0

7.31

6.86

mmol/l

0.54

261

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

509

1.30

1.27

1.6

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

731

1.25

1.26

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

970

0.79

1.25

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

326

0.64

1.22

22.8

16.3

1613.24

4376.77

nmol/l

0.47

316

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.04

1.22

1.0

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

305

1.38

1.20

1.0

0.66

1.40

u/ml

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

206

1.46

1.17

2.5

2.1

20529.50

20059.73

u/ml

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

310

0.64

1.17

18.7

12.2

833.60

4980.90

nmol/l

0.50

302

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

127

0.47

1.16

1.0

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

316

1.36

1.16

2.2

1.9

8.02

7.81

mmol/l

0.15

316

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

216

1.44

1.13

1.5

2.1

—

(3051651) Icteric interference index of Serum or Plasma

361

1.33

1.12

3.4

0.71

0.91

index

1.43

348

(40757373) Influenza virus identified in Isolate

114

0.44

1.12

2.2

1.4

—

(3042631) Mycobacterium sp identified in Specimen

781

1.22

1.10

3.5

2.8

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

321

1.34

1.07

1.9

3.1

42.88

39.11

0.65

180

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

739

1.22

1.07

3.6

2.6

13.15

13.25

0.52

729

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

153

1.50

1.06

1.6

1.4

152.40

140.86

nmol/l

0.13

114

(3051339) Copper [Moles/volume] in Blood

2.12

1.05

1.1

16.01

17.20

umol/l

—

(3010937) Rubella virus Ab [Presence] in Serum

2.00

1.00

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

214

1.40

0.99

1.5

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

214

1.40

0.99

1.5

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

352

1.31

0.99

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.71

0.98

1.7

1.9

—

1.55

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.67

0.97

2.8

1.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

397

1.29

0.97

1.1

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.95

0.97

7.9

7.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

301

1.33

0.96

1.2

1.3

5.88

6.02

mmol/l

0.28

282

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

469

1.26

0.96

1.1

300.38

295.25

mg/l

0.27

422

(3004451) EKG impression Narrative

319

1.32

0.95

1.2

1.3

—

(4146454) Self-monitoring of blood glucose

595

1.23

0.95

2.5

2.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

139

1202

1.16

0.95

2.4

2.5

31.98

33.76

umol/l

0.43

123

1084

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

141

1.49

0.94

1.1

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

479

1.25

0.94

1.1

185.00

166.58

titre

0.06

(44806071) Cardiolipin IgM antibody measurement

1.78

0.94

1.0

1.1

—

(3000012) Reticulocyte production index

834

1.19

0.93

1.7

2.3

0.93

0.91

0.10

557

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

209

1.39

0.92

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

159

1.45

0.91

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

289

1.32

0.87

1.8

2.0

2.40

3.35

u/field

0.34

203

(3052592) Norovirus Ag [Presence] in Stool

111

1.53

0.87

1.1

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.86

0.87

4.6

6.6

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.82

0.85

1.0

1.1

8.30

8.21

mmol/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

167

0.60

0.84

1.7

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

129

1.47

0.83

1.2

416.33

316.80

pmol/l

0.22

(40768806) Pleura Pathology biopsy report

667

0.81

0.82

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

422

0.76

0.82

1.3

1.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.88

0.81

1.0

—

(3012501) Base excess in Blood by calculation

132

1154

1.15

0.81

3.8

3.9

2.65

mmol/l

0.00

799

(3027315) Oxygen [Partial pressure] in Blood

133

1164

1.15

0.81

3.8

3.9

8.60

8.54

kpa

0.13

133

1137

(3013290) Carbon dioxide [Partial pressure] in Blood

132

1156

1.14

0.80

3.8

3.9

4.95

5.01

kpa

0.37

132

1130

(3028433) Virus identified in Specimen by Culture

198

1.37

0.79

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

766

1.18

0.79

1.9

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

419

1.24

0.79

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.82

0.79

1.7

2.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

210

1896

1.11

0.78

1.3

—

(40768441) Liver Pathology biopsy report

507

0.79

0.77

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

760

1.17

0.76

1.8

1.5

—

(3042733) HLA Ab [Presence] in Serum

149

1.41

0.75

6.2

4.9

—

(40768793) Breast Pathology biopsy report

261

2389

1.10

0.75

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

175

1.37

0.74

1.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

271

1.29

0.74

1.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

808

7710

1.05

0.73

3.2

4.4

5.85

28.67

ug/l

4.38

632

6195

(21494434) Karyotype in Bone marrow

542

1.20

0.73

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

818

0.84

0.72

1.0

1.1

—

(4212803) Bone marrow aspirate examination

1.61

0.72

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.58

0.71

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

620

0.82

0.70

1.7

1.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

857

0.85

0.69

1.4

31.73

33.59

g/l

0.61

782

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.67

0.68

1.1

5.94

5.88

mmol/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.60

0.68

9.9

9.3

4.78

5.20

mmol/l

0.36

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

302

1.26

0.67

1.4

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

302

1.26

0.67

1.4

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

302

1.26

0.67

1.4

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

302

1.26

0.67

1.4

1.8

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

119

0.59

0.67

5.4

2.7

401.14

1058.31

u/l

—

110

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

356

1.24

0.67

1.9

2.5

439.75

522.55

e6/l

0.85

288

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

119

1.43

0.66

3.0

2.2

4.94

34.60

ug/l

0.51

119

(3024869) Neuronal Ab [Presence] in Serum

1.49

0.66

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

1.79

0.66

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.51

0.66

1.1

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

856

1.15

0.65

1.1

183913.58

1007.63

iu/ml

0.47

173

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.57

0.65

3.7

2.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.50

0.63

1.2

56.55

79.13

ng/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

513

0.82

0.62

1.6

1.7

2.90

4.48

ug/l

0.68

393

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

102

0.59

0.62

1.5

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.61

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.48

0.60

2.9

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

1.48

0.60

1.1

1.2

62.77

65.08

ug/l

0.23

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.57

0.60

1.8

—

(3050794) Legionella sp Ab [Presence] in Serum

1.57

0.60

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

166

1.33

0.58

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

219

1.28

0.58

1.1

1.0

94.38

92.50

0.12

165

(40761536) Microorganisms panel - Urine sediment

529

5031

1.06

0.58

5.1

3.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.48

0.57

1.3

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

165

1808

0.91

0.57

2.6

3.8

27.41

43.40

u/ml

1.63

160

1746

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

450

1.18

0.53

5.0

6.8

22.68

36.03

ug/l

0.41

282

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.49

0.53

10.9

5.8

28.20

41.37

ug/min

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.49

0.53

2.6

3.0

0.27

0.69

u/field

1.54

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.54

0.53

2.0

1.4

0.23

1.65

mg/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

713

1.14

0.52

1.2

8.17

7.63

mmol/l

0.81

612

(3008037) Lactate [Moles/volume] in Venous blood

164

1505

1.09

0.51

3.7

2.9

1.43

1.57

mmol/l

1.99

156

1462

(3020650) Glucose [Presence] in Urine

224

1.25

0.50

2.1

1.7

0.00

0.04

estimate

1.08

224

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

202

0.74

0.50

1.5

2.0

2.88

1.62

ratio

0.95

191

(3035285) Chloride [Moles/volume] in Venous blood

688

1.14

0.49

3.0

2.3

106.47

105.22

mmol/l

2.53

681

(3033705) Calcium.ionized [Moles/volume] in Venous blood

680

1.13

0.48

3.0

2.3

1.21

1.20

mmol/l

1.39

673

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

280

1.22

0.48

2.6

5.2

—

148.91

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.52

0.48

1.6

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

592

0.86

0.47

1.4

1.3

6.64

6.41

mmol/l

0.24

551

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

137

1.31

0.47

1.1

1.2

—

(3012898) Urea [Moles/volume] in Urine

1.46

0.46

1.4

1.3

210.57

161.03

mmol/l

—

(3035880) pH of Pleural fluid

299

0.80

0.46

1.1

1.2

7.42

0.04

210

(1761482) Bacteria [#/volume] in Urine by Culture

166

1533

1.08

0.46

6.0

4.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.45

0.44

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.37

0.44

2.3

1.7

57.57

43.84

umol/l

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.61

0.43

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

688

1.12

0.42

3.0

2.3

4.06

4.03

mmol/l

0.30

681

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.56

0.42

1.0

0.02

0.06

u/ml

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.38

0.42

1.9

1.6

—

(40762814) Titanium [Mass/volume] in Blood

1.38

0.42

3.0

2.3

3.24

3.79

ug/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.43

0.41

1.2

1.0

2.89

10.76

u/ml

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.52

0.41

1.0

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.2

—

125.00

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.02

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.39

0.40

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.39

0.40

1.3

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.31

0.39

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.43

0.39

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.1

—

239.53

—

(3000060) B lymphocytes [#/volume] in Blood

142

1.27

0.38

1.2

2.1

0.87

0.21

e9/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.39

0.36

1.1

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.43

0.35

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

394

1.14

0.35

3.1

2.3

709.33

624.61

0.78

271

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.40

0.35

1.0

1.2

—

(3017569) Oxygen content in Arterial blood

320

1.16

0.34

2.4

2.2

15.71

15.94

0.18

320

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.34

0.34

1.3

1.1

—

(44806420) Estimation of glomerular filtration rate

803

0.91

0.33

2.9

2.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.30

0.33

1.3

3.5

65.47

27.06

mg/mmol

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

454

1.12

0.32

1.0

321.47

352.49

ng/l

0.28

324

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

455

1.12

0.31

1.0

833.61

695.34

ng/l

1.27

316

(3026051) Granulocytes/Leukocytes in Pleural fluid

101

1.29

0.31

1.0

1.5

32.57

21.80

—

(3016228) CD19 cells/cells in Blood

241

0.83

0.31

1.8

2.2

6.55

8.18

0.46

231

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

457

1.12

0.30

1.0

46.94

44.13

ng/l

0.13

321

(3029396) Erythrocyte agglutination [Presence] in Blood

1.31

0.30

1.8

2.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

661

0.91

0.29

1.3

1.4

24265.37

54023.92

e6/l

1.56

365

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

188

1784

1.06

0.29

3.0

2.9

1.53

mg/l

0.01

169

1619

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

626

0.91

0.27

1.2

—

(3011412) CD3 cells [#/volume] in Blood

539

1.10

0.26

1.8

2.4

1279.87

1147.86

e6/l

0.50

478

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

160

1.19

0.25

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.22

0.25

1.2

1.1

—

(3016750) Collection duration of Urine

293

1.13

0.24

3.3

2.2

499.79

496.77

min

0.09

225

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

152

1.18

0.23

1.1

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

114

1076

1.06

0.23

1.4

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

143

1502

0.95

0.22

2.1

3.5

254.97

732.03

u/ml

0.99

125

1358

(3001729) Color of Synovial fluid

1.22

0.22

1.0

1.6

—

(3047189) Immunofixation for 24 hour Urine

286

1.12

0.21

2.1

1.8

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.21

0.0

1.2

—

1.12

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.16

0.21

1.6

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

1.26

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

221

1.13

0.20

4.0

3.5

55.37

995.37

mg/l

0.50

156

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

114

0.79

0.20

2.3

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

193

1.14

0.19

1.4

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.18

0.19

3.5

2.6

0.55

0.64

ug/l

—

(40768800) Prostate Pathology biopsy report

550

0.93

0.18

1.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

223

1.12

0.18

1.6

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

174

0.86

0.17

1.8

1.9

1.50

2.32

ug/l

—

108

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

120

0.83

0.16

1.6

2.3

5.74

7.44

mmol/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.13

0.16

1.5

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

266

0.90

0.15

2.0

1.8

287.62

2885.01

e6/l

0.76

177

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.75

0.15

2.0

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

112

1.16

0.14

3.5

2.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

549

1.06

0.13

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

125

1294

0.97

0.13

4.6

3.2

20.25

26.76

mg/l

2.32

910

(3038515) Glucose [Moles/volume] in Venous blood

131

1267

1.03

0.13

4.1

3.0

7.53

7.66

mmol/l

0.21

123

1231

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

413

1.07

0.13

1.5

2.2

—

(3000285) Sodium [Moles/volume] in Blood

142

1.13

0.12

1.3

1.2

138.45

138.22

mmol/l

0.07

116

(40765096) Chromosome analysis panel by Banding

200

0.90

0.12

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

152

1.12

0.12

1.4

1.3

151.05

156.75

pmol/l

0.08

152

(3023199) Leukocytes [#/volume] in Pleural fluid

742

0.96

0.11

1.3

1.4

4489.22

3993.83

e6/l

0.06

519

(21494814) CD8 cells/Lymphocytes in Specimen

240

0.92

0.11

1.7

2.3

30.05

32.30

0.24

240

(3001019) Free T4 and TSH panel - Serum or Plasma

328

3227

1.02

0.10

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

777

7846

0.99

0.10

5.5

4.9

32.80

33.17

0.43

499

4968

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

228

0.92

0.10

1.9

1.6

1162.17

24386.75

e6/l

—

120

(3045142) Bone marrow Pathology biopsy report

713

1.04

0.09

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

174

1.09

0.09

2.8

3.3

70.70

147.53

ng/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

554

0.96

0.09

1.2

—

(3045788) Cell count panel - Pleural fluid

614

0.96

0.09

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

508

1.04

0.08

2.1

2.2

2.74

1.75

u/field

0.75

255

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.05

0.08

1.5

2.5

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.03

0.08

1.2

1.3

9.90

14.29

pmol/l

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.82

0.08

1.4

1.1

12.64

12.42

mg/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.09

0.08

1.1

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

352

1.05

0.08

1.9

1.5

—

(3048879) Bone marrow aspiration report

147

1.09

0.07

1.3

2.1

—

2.00

—

(3024932) HLA-DR beta [Type]

147

1.09

0.07

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

418

0.96

0.07

1.3

9.83

10.99

u/l

0.28

384

(3041806) Other cells [#/volume] in Blood by Manual count

0.85

0.07

1.6

1.4

0.59

0.51

e9/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

202

0.94

0.05

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

228

1.05

0.05

2.1

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

337

1.04

0.04

2.0

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

200

0.95

0.03

1.6

1.8

4.52

1.79

u/ml

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

567

1.02

0.03

2.4

26.05

19.66

iu/ml

0.28

(4015189) Microbial culture of sputum

141

1.06

0.03

3.5

2.2

—

(3024471) HLA-A [Type]

151

1.06

0.03

1.1

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

108

0.93

0.03

3.9

6.3

8.08

8.23

mmol/l

—

108

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

489

0.98

0.02

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

368

0.98

0.01

1.9

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

163

1.04

0.01

1.6

1.3

25.26

26.46

g/l

0.10

126

(3026692) Albumin [Mass/volume] in Peritoneal fluid

184

1.03

0.00

1.2

1.3

11.01

13.51

g/l

—

139

(3038071) Oxygen [Partial pressure] in Mixed venous blood

103

0.97

0.00

6.1

7.4

6.96

5.36

kpa

—

103

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

263

0.99

0.00

3.0

3.1

1.31

1.37

0.06

263

(3013727) Leukocytes other/Leukocytes in Blood

176

1.02

0.00

3.4

3.5

61.33

55.77

0.89

167

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

105

1.05

0.00

1.0

1.4

—

(40758292) HTLV I+II Ab panel - Serum

112

0.98

0.00

1.3

1.4

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.96

-0.00

1.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

20.38

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.91

-0.00

11.6

5.8

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.00

-0.00

1.0

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

4.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

470

1.00

-0.00

2.0

1.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.4

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.24

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

110

1.00

-0.00

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.89

-0.00

6.4

7.0

10.47

10.57

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.8

—

16.33

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.91

-0.00

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.93

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_TROCHANTERICBURSITIS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_TROCHANTERICBURSITIS	0.977 [0.88, 1.08]	0.657
Birth year	0.994 [0.99, 1.0]	0.126

During the follow-up period (1.1.1998 — 31.12.2019), 2785 out of 19542 females with M13_TROCHANTERICBURSITIS died.

Males

Parameter	HR [95% CI]	p-value
M13_TROCHANTERICBURSITIS	1.217 [1.05, 1.4]	0.007
Birth year	0.988 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 843 out of 4000 males with M13_TROCHANTERICBURSITIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_TROCHANTERICBURSITIS.

N-year risk	Females	Males
1	0.092%	0.227%
5	0.608%	1.348%
10	1.436%	3.34%
15	2.668%	6.879%
20	4.671%	11.839%

Relationships between endpoints

↥

Index endpoint: M13_TROCHANTERICBURSITIS – Trochanteric bursitis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Trochanteric bursitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints